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ABSTRACT 
Ligand design is a vital component of coordination chemistry, and the use of ligands for 
complexation of metal cations have been explored for many years. Several metal 
complexes of silver and palladium have been reported in literature and these complexes 
have been fully studied. I chose to study silver and palladium, because these metals are 
precious and are used in several industries such as electronics and jewelry industry and 
also in catalysis. In addition to economic incentives to recover these metals, it should be 
noted that these heavy metals often pose both environmental and health hazards. For 
example, low levels of silver have been found to lead to the death of aquatic animals. 
Herein, I describe the synthesis of a novel ligand, 4-[(2-imidazylethynyl)]-5-(2-
pyridylethynyl) veratrole and its silver(I) and palladium(II) complexes. The ligand was 
characterized by 1H, 13C NMR, and by elemental analysis. The single X-ray structure of 
the ligand and the palladium complex were also determined. 1H NMR titration revealed a 
1:1 complex formation between the ligand and silver, and the ligand and palladium 
cations. Long range plans involve the attachment of this ligands to a polymer support for 
the extraction of these cations from waste. Furthermore, I also described the X-ray 
structure of three iodoimidazole derivatives; 1-benzyl-2-iodo-1H-imidazole, 1-benzyl-4-
iodo-1H-imidazole and 1-benzyl-2-iodo-1H-benzimidazole and the halogen bonds that 
dominate the intermolecular interactions in each of these three structures.  
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INTRODUCTION 
Ligand design and synthesis continues to lead the line in modern coordination 
chemistry, due to its importance in many diverse areas of chemistry. These areas include 
catalysis,1,2 metallo-pharmaceuticals,3,4 metallo-suprachemistry5 metal cations sensors,6,7 
to name a few. Indeed, the importance of ligand design is underscored by the recent 
American Chemical Science Selects Virtual Issue focused on ligand design.8 A ligand is 
defined as an ion or molecule that binds to a metal atom to form a coordination complex. 
The bond between the metal and the ligand is formed from the donation of one or more 
electron pairs from the ligand to the metal, and this bond is referred to as a coordinate 
covalent bond.  Since the advent of coordination complexes by Alfred Warner, many 
ligands have been designed to specifically complex metals. Silver and palladium have 
received great attention over the years due to their unique properties. These properties 
have led to the utilization of these metals in electronic industry, jewelry industry, 
catalysis, to name a few.  
My project was to devise a ligand with the potential to form neutral complexes 
with silver and palladium cations.  The design plan was to modify a known trans- 
coordinating ditopic pyridyl ligand. The known trans-ligand was designed with a 1,2-
diethynylbenzene core and the trans-coordination of silver and palladium cations was 
demonstrated.9 In the design of this ditopic ligand, I planned to incorporate an imidazoyl 
moiety in place of one of the pyridyl groups with the expectation that neutral silver and 
palladium complexes could be formed in solution. To evaluate the potential application 
of the ligand, the long-term goal would involve the attachment of the ligand to a polymer 
support for the extraction of silver and palladium cations from waste.      
  
2 
Silver  
It is a soft, white lustrous transition metal belonging to group 11 on the periodic 
table, below copper and above gold. It has an atomic number of 47, with three main 
oxidation states (0, +1, and +2) and two naturally occurring isotopes, 107Ag and 109Ag, 
with relative abundances of 51.84% and 48.16% respectively. Silver has the highest 
thermal conductivity, electrical conductivity, as well as reflectivity of all metals on the 
periodic table. It is also a soft Lewis acid with affinity for Lewis bases containing 
nitrogen, sulfur and oxygen atoms.  Most of the world supply of silver is produced as a 
by-product of copper, gold, lead and zinc refining. These unique properties of silver led 
to numerous application of this metal in different areas 
Uses and toxicity of silver. Silver is traditionally used in photography, 
money/coins, electronics, medicine, jewelry, silverware, clothing and in other areas. 
However, amongst all other uses of silver, its most recent use in synthesis of nanowires 
has attracted much attention because of their potentials application in electronic 
devices.10,11 These include their use as flexible transparent conductors in flat screens, 
solar cells and transparent heaters.11 Silver is used to make smart fabrics for aesthetics 
and various other purposes. The antimicrobial and antibacterial properties of silver has 
been exploited in medicine, where it is used for treatment of wounds and also for water 
purification. 
Silver ion is one of the most toxic heavy metal ions, surpassed only by mercury, 
and has therefore been assigned to the highest toxicity class, together with cadmium, 
chromium (VI), copper, and mercury.12,13 Surprisingly, the toxicity of this metal was not 
investigated until the mid-70’s.14 In subsequent years, research towards understanding the 
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environmental toxicity of silver has been carried out, and its various adverse effects are 
now known. Most silver released in the environment do remain in the soil or waste water 
sludge15 and are lethal to both plants and sea animals.16,17 Low levels of silver in the 
environment have been found to lead to death of aquatic animals,18 which might have an 
extended consequence on humans, hence, the need for a recovery process or technique 
for removal of this metal from the environment. 
Coordination chemistry of silver(I). The coordination chemistry of silver with 
nitrogen donors, particularly with polypyridyl ligands, is very rich because of the flexible 
coordination sphere of this cation and its ability to form, both in solution19 and in solid 
state. The coordination flexibility of this cation allows for coordination with a variety of 
ligands designed for different coordination geometries.20 Silver(I) is a soft metal center 
with high affinity for soft nitrogen ligands.21 Over the years, silver(I) has been thought to 
have strong preference for linear coordination,22 but a study by Young et al., reveals that 
out of 3319 solid structures of silver(I) complexes, 24 % were two coordinate, 23 % three 
coordinate, 44 % four coordinate and the remaining 9 % showed coordination geometries 
greater than four.23 The coordination geometry flexibility of this cation has been 
attributed to its lack of stereochemical directionality as a result of its filled d-shell which 
makes it difficult to predict the geometry of a silver complex beforehand.20 An example 
of each of the three common geometries formed with pyridyl ligands are shown in Figure 
1. These geometries show the flexibility of this metal, and its ability to form both in 
solution and it solid state, which makes the study of the complexes formed by this metal 
even more interesting. 
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Figure 1. Representative pyridine complexes with silver(I).  (A) Linear complex.24 (B) 
Trigonal complex.25 (C) Tetragonal complex.26 
 
 
Palladium   
 Palladium is a soft silver-white metal belonging to group 10 on the periodic 
table, below nickel and above platinum, with atomic number of 46. Palladium commonly 
exists in three oxidation states: 0 (metallic), +2 and +4. Palladium is composed of seven 
isotopes, of which six of them are stable, 102Pd, 104Pd, 105Pd, 106Pd, 108Pd and 110Pd.  The 
most stable radioisotope is 107Pd with a half-life of 6.5 million years. Palladium is mostly 
obtained from ores along with copper, gold, nickel and platinum. 
  Uses and toxicity of palladium. Palladium is an important metal majorly used 
as a catalytic converter in automobiles to convert harmful hydrocarbons, carbon 
monoxide and oxides of nitrogen emitted from automobiles to less harmful carbon 
dioxide, water vapor, and nitrogen. It is arguably the most used transition metal in 
organic synthesis. Notable mention, is its use as a catalyst in virtually all carbon-carbon 
cross coupling reactions.27 It is used to make jewelries, used in electronic industry as 
ceramic capacitors, found in laptops and phones. It is also used in dental alloys for dental 
fillers.  
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 Palladium has low toxicity and little recorded impact in the environmental. 
However, the sensitization risk of this metal is its major source of health concern in 
humans. Low doses of this metal causes allergic reactions such as skin and eye irritations 
in humans.28 High doses of palladium could be malicious. Test on mice exposed to this 
metal shows that it could be carcinogenic,29 although no clear case of this risk has been 
reported in humans. Some plants are killed from low levels of palladium salts in the 
environment, although most plants tolerate it.28 Given the use of heavy metals like 
palladium in automobile catalytic converters, there is concern that this is a potential entry 
point for palladium in the environment.  
Coordination chemistry of palladium(II). Palladium(II) complexes are one of 
the commonly used catalyst in chemical transformations. The geometry of these 
complexes play an important role in catalysis.30 The most favorable geometry adopted by 
palladium(II) complexes, is the square planar geometry. Two square planar palladium(II) 
complexes are shown in Figure 2.9,31  
A
N
N
Pd ClCl
                                 B 
N N
Pd
NC CN  
Figure 2. Two square planar palladium(II) complexes.9,31 
 
 
          It is pertinent to note that the spatial position of the pyridyl groups in complex A, 
are ideal to complex palladium as evidenced by the fact that the bond angles about the 
palladium are essentially perpendicular, with an N-Pd-Cl bond angles of 89.96º and 
89.85° (Fig 2A).9 In contrast to the second complex in Figure 2B, the angles about the 
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palladium deviate from orthogonality (with N-Pd-CN bond angles of 95.92º and 96.58º) 31 
due to the narrow bite angle of the β,β’-dipyridyl ligand. 
 
Dipyridyl ligands 
Among dipyridyl ligands, β,β′-bipyridine and 1,10-phenanthroline are especially 
common ligands used in the synthesis of wide variety of metal complexes.32–35 Several 
trans and cis-coordinating ligands have been synthesized from bipyridyl moieties, and 
they have been shown to be important ligands in coordination chemistry. A trans-
spanning 1,2-bis(β′ pyridylethynyl)benzene  ligand was first reported by Bosch et al.  He 
also reported the silver(I) and palladium(II) complexes of this ligand (Figures 3).  
N
N
Ag+/Pd2+
N
N
Ag
N
N
PdCl Cl
+
 
Figure 3. 1,2-bis(β′ pyridylethynyl)benzene and its silver(I) and  palladium(II) 
complexes.9  
 
 
However, Thummel independently reported two palladium(II) complexes of 1,2-
bis(β′ pyridylethynyl)benzene.36 The dimethoxy analogue of 1,2-bis(β′ 
pyridylethynyl)benzene  ligand was independently prepared by Bunz, et al. He reported 
other conformations, apart from the trans-coordinating conformation that the ligand 
could adopt to accommodate larger cationic centers such a rhodium.37 Even though cis-
bidentate ligands are known to effect oxidative addition and reductive elimination steps 
in catalysis, which is believed to proceed at the cis-position of the metal center (Figure 
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4),30 there are still few examples of transition-metal-catalyzed reactions with trans- 
bidentate ligands. 
 
Figure 4.  Oxidative addition and reductive elimination of cis-transition metal complex. 
 
          For example, Ueda et al. reported a palladium catalyzed Heck reaction using a rigid 
trans-bidendate ligand.38 Also, Suzaki et al. in 2011 reported a trans-palladium complex 
of 1,2-bis(2-pyridylethynyl) benzene used to catalyze the Mizoroki–Heck cyclization of 
difunctionalized substrates.39 Furthermore, Atobe reported an oxidative homocoupling of 
terminal acetylenes co-catalyzed by a trans-coordinating ligand,1-(2-pyridylethynyl)-2-
(2-thienylethynyl) benzene.40 
 
Ligand Design 
          Since silver is a soft acid, it has a high affinity for nitrogen containing ligands such 
as ligands containing imidazole and pyridine groups. While Figures 1, 2 and 3 show 
pyridine-based ligands, there are many silver complexes with imidazole based ligands.41– 
43 Two examples of linear imidazole-silver complexes are shown in Figure 5. With the 
knowledge that imidazole and pyridine based ligands could be used to synthesize silver 
complexes, we reasoned we could design a related trans-coordinating ligand based on the 
combination of a pyridyl group with an imidazoyl moiety. 
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S
N
O
O
Ag
O
N NH N N Ag N
N
O2N O2H
O2N
NO2
NO2
HO2
 
Figure 5. Imidazole-silver complexes.41,43 
 
I reasoned that following coordination to the more basic imidazole, the intramolecular 
reorganization to the trans-complex could be followed by deprotonation in aqueous 
conditions resulting in the formation of a neutral complex as shown in Figure 6. After 
evaluating the effectiveness of this ligand, the long-term plan would involve the 
attachment of this ligands, or a variation, to a polymer support for the extraction of silver 
and palladium cations from waste.  
 
MeO
MeO
N
N
H
N
MeO
MeO
N
N
H
N
MeO
MeO
N
N
N
Ag
+Ag
Ag+ -H+
 
Figure 6. Formation of neutral silver(I) complex with the ligand. 
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RESULT AND DISCUSSION 
 
          I reasoned that the desired ligand could be synthesized by sequentially coupling 2-
ethynylpyridine and 2-ethynylimidazole with an ortho-diiodobenzene. Given that 2-
ethynylypyridine is available commercially at moderate cost, we planned to add the 
ethynylpyridine first as shown in the retro-synthetic scheme in Figure 7. 
 
I
N
N
N
H
N
H
N
N
N
I
I
 
Figure 7. Retro-synthetic scheme for ligand design. 
 
          A brief literature search on Sonogashira coupling involving iodoimidazoles and 
terminal alkynes revealed that the coupling only proceeded with the imidazole N-H 
protected.44–55 While the reason for this has not been elucidated, it could be due to the 
deprotonation of the slightly acidic imidazole hydrogen by the triethylamine (base) used 
in Sonogashira coupling. As a result, we developed a specific strategy to achieve the 
synthesis of our ligand (Figure 8). Thus, synthesis of 2-ethynylimidazole could be 
achieved via the synthetic route shown in reaction 1 in Figure 8. ‘P’ represents a 
protecting group and two different groups were employed in the synthesis of the target 
compound, which would be discussed later.  
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MeO
MeO I
N
N
N
P MeO
MeO
N
N
N
MeO
MeO
I
NMeO
MeO
MeO
MeO
I
I
N
N
H
N
N
P
N
N
P
I
N
N
P
P
MeO
MeO
N
N
N
H
a b c
d e
f
g
(1)
(2)
(3)
Figure 8. Synthetic route used for the synthesis of the desired imidazole-pyridine ligand. 
           
          Diiodoveratrole could be synthesized from commercially available dimethoxy-
benzene. I decided to use veratrole because the methoxy groups are important for facile 
introduction of two ortho-iodine atoms. Also, protons on the two methoxy groups have 
unique NMR chemical shifts when the iodine atoms are replaced. Two chemical shifts are 
observed upon substitution of one of the iodine while a single chemical shift is observed 
upon substitution of the two iodine atoms. Thus, the methoxy group serve as an NMR 
signature for differentiating between the mono-substituted ethynylpyridyl product and its 
di-substituted counterpart. The mono-substituted 2-ethynylpyridine product can be 
synthesized via the route shown in reaction 2 in Figure 8. While the synthesis of the 
desired ligand was achieved via reaction 3 in Figure 8. For choice of ‘P”, I decided to use 
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the benzyl group since it was relatively cheap and could be deprotected under mildly 
acidic conditions. 
 
1-Benzyl-2-iodo-1H-imidazole, 2 
To synthesize 2-ethynylimidazole, via the benzyl protecting group route, the first 
step involved the benzylation of imidazole followed by iodination to afford the precursor 
required to synthesize 2-ethynylimidazole as shown in Figure 9. 
 
N
H
N Benzylbromide, CH3CN
Reflux, 2 h 30 mins N
N
Ph
1. n-BuLi, THF, -78 oC
2. I2, 3 h N
N
Ph
I
1 (93%) 2 (62%)
K2CO3
 
Figure 9. Synthesis of 1-benzyl-2-iodo-1H-imidazole, 2.   
 
Attempted synthesis of 1- (benzyl)-2-[2-(trimethylsilyl)ethynyl]imidazole,  2b 
 Several attempts to couple compound 2 with trimethylsilyl acetylene via a 
Sonogashira coupling failed (Figure 10). I tried to use different solvents such as 
dichloromethane and tetrahydrofuran. Also, I varied the temperature and also used a 
different palladium source(palladium tetrakis) but all these proved futile. 
 
N
N
Ph
I Si
N
N
Ph
Si
2b  
Figure 10. Unsuccessful synthesis of 1-(benzyl)-2-[2-(trimethylsilyl)ethynyl]imidazole, 
2b. 
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          Compound 2 was recrystallized from a mixture of 9/1 hexane-ethylacetate mixture 
to afford white needle like crystals. A good crystal for X-ray diffraction was selected and 
the X-ray structure was solved. Interestingly, the X-ray structure of 2 showed a strong C-
I----N halogen bond which connects the molecules into a one-dimensional zigzag ribbon 
(Figure 12).  The asymmetric unit of the X-ray structure of 2 contains a single molecule.  
The phenyl group is essentially orthogonal to the imidazole group with the dihedral angle 
between the planes defined by the phenyl C atoms and the imidazole nitrogen and carbon 
atoms of 84̊. The phenyl proton H6 is positioned above imidazole nitrogen N1 with 
torsional angle N1-C4-C5-C6 = 13.0 (4)̊ and the H6···N1 distance of 2.58 Å compared to 
the sum of the van der Waals radii of 2.75 Å.56 There is also a close contact between one 
of the benzyl protons and iodine atom with a H4B···I1 distance of 3.04 Å compared to 
the sum of the van der Waals radii of 3.18 Å.56 The three dimensional structure of 2 
features an imidazole N···I halogen bond as shown in Figure 11. The distance N2···I1 is 
2.8765 (2) Å which is 81% of the sum of the van der Waals radii of 3.53 Å.56 
 
 
Figure 11. Structure of 2 showing the imidazole N···I halogen bond.                                                                                                                                                 
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          The halogen bond is almost linear with a C-I···N angle of 174.42 (9) ̊.57 Linear 
one-dimensional ribbons of zig-zag halogen bonded molecules of 2 dominate the three-
dimensional structure as shown in Figure 12. These one-dimensional ribbons run parallel 
to the a-axis and are close packed with no other significant intermolecular interactions. 
The CCDC # for compound 2 is 1518620. 
 
Figure 12. One-dimensional zig-zag halogen bonded ribbon in the X-ray structure of 2. 
 
Literature search revealed that very few studies have been done on halogen bonding 
involving iodoimidazoles. Therefore, this interesting result instigated the exploration of 
halogen bonding in two other 1-benzyl iodoimidazole derivatives.  
 
1-Benzyl-2-iodo-1H-benzimidazole, 4 
          Compound 4 was synthesized from commercially available benzoimidazole using a 
slightly different procedure to that used to synthesize 2 (Figure 13). Compound 4 was 
recrystallized from a mixture of 3:2 hexane/ethylacetate to afford white rodlike crystals 
suitable for X-ray analysis. Several attempts to couple compound 4 with 
trimethysilylacetylene via a Sonogashira coupling were unsuccessful.  
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Benzylbromide
NaH, THF, 0 oC to RT 1. n-BuLi, THF, -78 oC
2. I2N
H
N
N
N
Ph
3 (72%)
N
N
Ph
4 (54%)
I
 
Figure 13. Synthesis of benzyl-2-iodo-1H-benzimidazole, 4. 
 
In contrast to compound 2, the X-ray structure of 4 is dominated by a C-I···π 
interaction (Figure 14). The structure of 4 also contains a single molecule in the 
asymmetric unit with a dihedral angle between the imidazole and benzyl rings of 86̊.  In 
this structure, the phenyl proton H9 is positioned above N1 with dihedral angle N1-C8-
C9-C14 equal to -13.4̊. There is also a C-I···π interaction to the phenyl ring of an 
adjacent molecule resulting in a C-I···π bonded molecular dimeric motif.57 
 
Figure 14. Structure of the C-I···π halogen bonded dimers formed in the structure of 4, 
showing atom labelling and the C-I···π phenyl interaction with displacement ellipsoids 
drawn at the 50% level in A and as a space-filling model in B. 
 
In the C-I···π bonded dimer of 4, the C-I bond is directed towards the phenyl 
carbon, C13, of the adjacent molecule with a C1-I1 ···C13 angle of 178.66 (1) ̊ and an 
I3···C13 distance of 3.3929 (4) Å.  This distance is 92% of the sum of the van der Waals 
radii of 3.68 Å 41. The C-I···Cg1 distance is 3.4562 (4) Å where Cg1 is the centroid of 
the phenyl ring C9-C14.  The C-I···Cg1 angle is 156.94 (1)̊. There is also an 
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intramolecular C-H···π interaction since the benzyl proton H14 lies above the imidazole 
ring with a N1-C8-C9-C14 torsional angle of -13.4̊. This interaction is labelled “x” in 
Figure 15. The H14-N1 distance is 2.51 Å and the C14-H14···N1 angle is 101.19̊.  The 
H14···Cg2 distance is 2.82Å, where Cg2 is the centroid of the imidazole ring (N1-C1-
N2-C2-C7), and the C14-H14···Cg2 angle is 125̊. 
The three-dimensional packing of 4 involves multiple cohesive interactions: two 
intermolecular C-H···π interactions and two π---π interactions. Benzoimidazole hydrogen 
H5 has C-H···π interaction with the pendant phenyl ring labelled “y” in Figure 15.  The 
H5···Cg1 distance is 2.78 Å and the C-H···Cg1 angle is 149̊ where Cg1 is the centroid of 
phenyl ring. Benzyl proton H13 has an interaction with the benzoimidazole benzene ring, 
labelled “z” in Figure 15 with a H13···Cg3 distance 2.94 Å and a C13-H13···Cg3 angle 
of 141̊. Cg3 is the centroid of the benzoimidazole ring. The benzoimidazole groups are 
alternately π-stacked (ππ in Figure 15) with the benzene rings overlaid and slightly offset. 
The CCDC # for compound 4 is 1518622. 
 
 
Figure 15. Partial view of the three dimensional packing of 4 viewed along the a-axis.  
The C-I···π interaction is labelled lπ and the C-H··· interactions labelled x, y and z and 
the π-stacking as ππ. 
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1-Benzyl-4-iodo-1H-imidazole, 5 
            Compound 5 was synthesized from commercially available 4(5)-iodo-1H-
imidazole via a similar procedure to that used to synthesize 3 (Figure 16) and was 
recrystallized from a 1:2 mixture of acetonitrile and methanol to afford good crystals for 
X-ray diffraction. 
 
Benzylbromide, 40 min
NaH, THF, 0 oC to RT, 40 min
N
H
N
I N
N
I
Ph
5 (99%) 
Figure 16. Synthesis of 1-benzyl-4-iodo-1H-imidazole, 5. 
 
           The X-ray structure of 5 contains a single molecule in the asymmetric unit with a 
bent shape. The phenyl group is also almost orthogonal to the imidazole group with the 
dihedral angle between the planes defined by the phenyl and imidazole rings of 84̊. The 
phenyl ring is not oriented above the imidazole ring, with a torsional angle C6-C5-C4-N1 
of -52.0 (2)̊. The three-dimensional structure has a weak iodo···π-interaction with the 
pendant phenyl ring of an adjacent molecule that results in the formation of C-I···π 
halogen bonded dimers57 as shown in figure 17. 
          In the C-I···π bonded dimer of 5, the C-I bond is directed towards the phenyl 
carbons, C7 and C8, of the adjacent molecule with I1···C7 and I1···C8 distances of 3.551 
(2) and 3.5534 (2) Å respectively both approximately 96% of the sum of the van der 
Waals radii of 3.68 Å56. The C2-I1···C7 and C2-I1···C8 angles are 152.99 (1) and 171.24 
(1) ̊ respectively. The C-I···Cg1 distance is 3.5861 (2) Å where Cg1 is the centroid of the 
phenyl ring, C5-C10. There are two other close contacts in the three-dimensional 
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structure of 5. One of these is a nonconventional C-H···N hydrogen bond between N2 
and a benzylic hydrogen atom of an adjacent molecule with a N2···H4B distance of 2.55 
Å, which is 93% of the sum of the van der Waals radii of 2.75 Å56.   
 
 
Figure 17. Structure of 5 showing atom labelling and the C-I···π phenyl interaction with 
displacement ellipsoids drawn at the 50% level in A and shown as a space-filling model 
in B. 
 
          The C-H···N angle is 157.5β̊. There is a close H···H contact of 2.26 Å between 
H4B and H7 of an adjacent molecule.61 The CCDC # for compound 5 is 1518621. 
Further search into literature revealed a better protecting group, 1-[[2-
(trimethylsilyl)ethoxy]methyl] (SEM) for imidazoles involved in Sonogashira coupling. 
This group had previously been used to protect imidazoles used in Sonogashira 
couplings.48,53  
 
1-[[2-(Trimethylsilyl)ethoxy]methyl]-2-ethynylimidazole, 9 
The successful strategy involves protection of imidazole as the SEM ether 
followed by iodination, Sonogashira coupling with trimethylsilylacetylene and finally the 
deprotection of the trimethylsilyl group (Figure 18). In this sequence, imidazole was 
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protected with SEM group as described by Dobowchik et al.58 The crude SEM-imidazole 
was directly iodinated via a variation of the procedure by Knapp et al.59  
 
N
N
H
1. NaH, THF, 0oC to RT, 30 min
2. SEMCl, 30 min N
N
O
Si
1. nBuLi, THF, -78oC
2. I2, 3 h N
N
SEM
I
6 (99%) 7 (56%)
N
N
SEM Si
Si
NEt3, Pd(PPh3)2Cl2, CuI
60 oC, 40 h
8 (44%)
KOH, EtOH
r.t, 2 h N
N
SEM
9 (65%)
Figure 18. Synthesis of 1-{[2-(trimethysilyl)ethoxy]methyl}-2-ethynylimidazole, 9. 
 
After chromatographic purification, imidazole, 7 was coupled with 
trimethylsilylacetylene in low yield. Direct deprotection of 8 yielded the target 
ethynylimidazole in moderate yield. The overall yield of the SEM protected 
ethynylimidazole from imidazole was a meager 16%. Some reactions in this sequence 
posed some problems. For example, compound 6 could not be purified by column 
chromatography because it could not be seen on TLC plate under a UV lamp. It was also 
difficult to purify compound 8 by column chromatography due to very close Rf values 
between 8 and other impurities. 
 
4-Iodo-5-(2-pyridylethynyl) veratrole, 11 
 This synthesis started with iodination of commercially available veratrole (1,2-
dimethoxybenzene via a similar procedure to that reported by Lacour et al.60 to yield 4,5-
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diiodoveratrole, 10, in excellent yield after recrystallization from a mixture of hexane and 
ethylacetate. The methoxy groups permitted the facile introduction of two ortho-iodine 
atoms. To optimize the yield of the target compound, 11, relative to competitive 
disubstitution, we reacted excess diiodoveratrole (10), 2 equiv. with 2-ethynylpyridine. 
Sonogashira coupling under usual conditions followed by flash chromatography yielded 
11 in moderate yield. The disubstituted product, 1,2-bis(β′ pyridylethynyl) veratrole, was 
also isolated as a brown solid, 26 %, along with recovered unreacted 10 (see Figure 19). 
The NMR data for 11 match those by Bunz et al.61 and will therefore not be discussed in 
detail. 
 
MeO
MeO
H5IO6, I2, MeOH
70 oC, 5h MeO
MeO
I
I
10 (91%)
MeO
MeO
I
N
 Pd(PPh3)2Cl2, CuI,
11 (62%)
TEA, r.t, 72 h
N
Figure 19. Synthesis of 4-iodo-5-(2-pyridylethynyl) veratrole, 11. 
 
4-[1-(2-Trimethylsilylethoxymethyl)]-1H-imidazylethynyl [5-(2-pyridylethynyl)] 
veratrole, 12 
          Having synthesized and characterized the following compounds, 4-iodo-5-(2-
pyridylethynyl) veratrole and 1-[[2-(trimethylsilyl)ethoxy]methyl]-2-iodoimidazole, the 
next step was to combine the two components via a Sonogashira coupling to give 12, the 
precursor to the desired ligand, 13 as shown in Figure 20. The Sonogashira coupling of 4-
iodo-5-(2-pyridylethynyl) veratrole was performed in a mixture of THF and triethylamine 
due to the low solubility of 11 in trimethylamine.  After flash chromatography, the 
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compound was obtained as a red oil in poor yield. The compound was initially 
characterized by 1H NMR. The 1H NMR spectrum is shown in Figure 21.   
 
Pd(PPh3)2Cl2, CuI
NEt3/THF, 60 oC
MeO
MeO
N
N
N
SEM
119
12 (46%)
MeO N
N
H
N
MeO
13 (50%)
TFA
 
Figure 20. Synthesis of 4-[1-(2-trimethylsilylethoxymethyl)]-1H-imidazylethynyl [5-(2-
pyridylethynyl)] veratrole, 12. 
 
 
Figure 21. 1H NMR 4-[1-(2-trimethylsilylethoxymethyl)]-1H-imidazylethynyl [5-(2-
pyridylethynyl)] veratrole, 12 in 99.9 % CDCl3. 
 
The 1H NMR spectrum has 11 sets of peaks as expected. Several of the peaks are 
distinctive and allow us to establish that each piece of the molecule is present. Thus, the 
1H doublet at 8.65 ppm (a) corresponds to the H ortho to the pyridine N, the 6H singlet at 
3.89 ppm (f) corresponds to the two methoxy groups on the central methoxy benzene 
ring, and the 2H singlet at 5.52 ppm (k) corresponds to the methylene group between O 
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and N in the SEM protecting group. The relative integrations of these peaks are 
effectively 1:6:2 as expected for the SEM ligand, 12. The spectrum is complex and will 
therefore be analyzed using two expanded spectral windows. The first spectral window 
shows only the aromatic protons (Figure 22). 
 
  
Figure 22. 1H NMR of 12 in 99.9 % CDCl3 showing only the aromatic proton peaks. 
 
          Proton ‘a’ is the most deshielded proton and therefore the signal for ‘a’ appears at 
8.65 ppm as a doublet. It is split by proton ‘b’ with a coupling constant of 3J = 4.8 Hz. Hc 
(7.66 ppm) appears as a triplet of doublet. The proton Hc is split into a large triplet by 
coupling with ortho protons, Hb and Hd with 3J = 7.8 Hz and long-range coupling by Ha 
with 4J = 2.0 Hz. The signal for proton Hd appears at 7.55 ppm as a doublet and is 
coupled by ortho proton, Hc with 3J = 7.8 Hz. The proton signal Hb appears at 7.23 ppm 
as a doublet of doublet of doublet. Proton Hb has ortho coupling to Hc with a coupling 
constant of 3J = 7.8 Hz, and long range (meta) coupling with Ha (4J = 5.0 Hz) and long 
range (para) coupling with Hd (4J = 1.2 Hz). As expected, the signals for protons Ha, Hb, 
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Hc and Hd have relative integrations of 1:1:1:1. The singlet at 7.18 ppm was assigned to 
Hg, while the other singlet at 7.08 ppm which integrates for three hydrogens corresponds 
to phenyl proton He, and imidazole protons Hi, Hj. The second spectral window shown in 
Figure 23, includes all the non-aromatic protons. 
 
 
Figure 23. 1H NMR of 12 in 99.9 % CDCl3 showing only the non-aromatic protons. 
 
          The downfield signal labeled ‘k’ corresponds to the methylene protons flanked by 
two electronegative elements, O and N. This is a singlet that integrates for two 
hydrogens. The peak at 3.89 ppm (f) is a singlet that integrates for six hydrogens and 
corresponds to the methoxy hydrogens. The peak at 3.49 ppm is a triplet and it is 
assigned to the methylene protons (l) flanked by an oxygen atom. These protons are 
coupled by adjacent methylene protons, Hm with coupling constant 3J = 8.4 Hz. The 
triplet at 0.76 ppm then corresponds to the methylene protons, Hm with the same 
coupling constant. The relative integrations of the signals for Hk, Hl and Hm are 2:2:2 as 
expected. Finally, the singlet at -0.15 ppm integrates for 9 hydrogens and corresponds to 
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the trimethylsilyl hydrogens from the SEM group (n). The 13C NMR shown in Figure 24 
also confirmed the presence of the entire piece of the molecule.  
 
 
Figure 24. 13C NMR of 12 in 99.9 % CDCl3. 
 
          Several peaks could be assigned by the comparison to the NMR of the individual 
precursors. For example, the signal at 150.2 ppm corresponds to carbon ‘a’ on the 
pyridine ring. The corresponding chemical shift in precursor 11 was 150.5 ppm. The 
signal at 56.2 ppm corresponds to the carbon ‘b’ on the central benzene ring. The 
corresponding chemical shift observed for the methoxy groups in the precursor, 10 was 
56.3 ppm and thesignal at 136.3 ppm corresponds to carbon ‘c’ on the imidazole ring 
with a corresponding chemical shift in the precursor, 9 of 131.1 ppm. In total, there are 
14 peaks in the aromatic region between 150.2 and 114.7 ppm. These 14 peaks 
correspond to 6, 5 and 3 carbon atoms on the benzene, pyridyl and imidazoyl rings 
respectively. The four ethynyl carbon peaks are seen at 91.7, 91.6, 88.1 and 81.5 ppm 
respectively. The peaks at 75.6, 66.6, 17.7 and -1.4 ppm corresponds to the carbon atoms 
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on the SEM group, while the peak at 56.2 corresponds to the methoxy carbon from the 
benzene ring. 
 
4-[(2-Imidazylethynyl)]-5-(2-pyridylethynyl) Veratrole, 13 
In contrast to other silyl based protecting groups, there are relatively few reported 
methods for deprotection of the SEM protecting group. Two of the milder methods uses 
either tetrabutylammonium fluoride or concentrated hydrochloric acid to effect 
deprotection. Unfortunately, Honda et al. reported that neither of these gave positive 
result with an alkyne present in the molecule.53 The Honda group then reported a new 
procedure, which employed trifluoroacetic acid to effect deprotection of the SEM 
group.53 Thus, 13 was obtained from 12 by treating it with trifluoroacetic acid. Flash 
chromatography, followed by recrystallized from a mixture of acetonitrile and 
dichloromethane gave crystals suitable for single X-ray structure determination.    
  Compound 13 was first characterized by 1H and 13C NMR spectroscopy. The 1H 
NMR was recorded in both deuterated dimethylformamide (DMF-d7) and Chlorofoam. 
The spectrum recorded in DMF-d7 is shown in Figure 25. Additionally, the elemental 
analysis of 13 was performed and the observed compositions of C, H and N was within ± 
0.4 % of the calculated values for 13. From the spectrum above, we observed the 
disappearance of the SEM protecting group peaks, Hk (5.52 ppm), Hl (3.49 ppm), Hm 
(0.76 ppm) and Hn (-0.15 ppm) that were present in compound 12 and the appearance of 
imidazole hydrogen, Hp at 13.20 ppm. This confirms the complete replacement of the 
SEM group by hydrogen. The appearance of imidazole N-H proton (Hp) and the presence 
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of Ha and Hf peaks at 13.20, 8.76 and 3.96 ppm respectively confirms that each piece of 
the molecule was present. 
 
Figure 25. 1H NMR of 4-[(2-Imidazylethynyl)]-5-(2-pyridylethynyl) veratrole, 13 in 99.9% 
DMF-d7. 
 
           However, since 1H NMR of 13 was recorded in DMF, it is reasonable to observe 
shifts in the peaks due to significant difference in polarity and solvation ability of the two 
solvents (chloroform and dimethylformamide). The spectral window showing only the 
aromatic region is shown in Figure 26. The imidazole N-H proton, Hp, was not observed 
when the NMR spectrum was recorded in CDCl3. The pyridyl protons are Ha-Hd and the 
imidazole protons are Hi and Hj (on carbon) and Hp (on nitrogen). Proton ‘p’ is the most 
deshielded proton and therefore the signal for proton ‘p’ appears at 13.20 ppm which 
corresponds to imidazole N-H proton. The signal for Hp is broad because of the 
intramolecular hydrogen bonding of this proton with the pyridine nitrogen. The proton, 
Ha was observed at 8.76 ppm and appears as a doublet. Proton Ha is split by proton Hb 
with a coupling constant of 3J = 4.4 Hz. The signal for proton Hc appears at 7.93 ppm as 
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a triplet of doublet. Proton Hc is split into a large triplet by coupling with ortho protons, 
Hb and Hd with 3J = 7.8 Hz and long-range coupling to Ha with 4J = 1.6 Hz.  
 
 
Figure 26. 1H NMR of 13 recorded in dmf-d7 showing only the aromatic peaks. 
 
The signal for proton Hd appears at 7.79 ppm and is coupled to ortho proton, Hc 
with 3J = 7.8 Hz. The signal for proton Hb appears at 7.23 ppm as a doublet of doublet of 
doublet. Proton Hb has an ortho coupling to Hc with a coupling constant of 3J = 7.6 Hz, 
and long range (meta) coupling with Ha (4J = 4.8 Hz) and long range (para) coupling with 
Hd (4J = 1.2 Hz). As expected, the signal for protons Ha, Hb, Hc, Hd peaks had relative 
integrations of 1:1:1:1. The singlet at 7.34 ppm which integrates for two hydrogens 
correspond to the phenyl protons He and Hg while the other singlet at 7.27 ppm which 
also integrates for two protons corresponds to imidazole protons Hi and Hj.  The 13C 
NMR shown in Figure 27 also confirms the success of the deprotection. From the 13C 
NMR spectrum, we observed the disappearance of the four carbon peaks associated with 
the SEM group (d,e,f, g) present in compound 12. Overall, 11 peaks were observed in the 
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aromatic region, ranging from 150.2 to 112.6 ppm. There is an overlap of two imidazole 
carbon peaks as well as two phenyl-carbon peaks. The four ethynyl carbon peaks were 
observed between 90.8 and 85.4 ppm and finally the methoxy peak at 56.3 ppm.  
 
 
 Figure 27. 13C NMR spectrum of 13 in 99.9 % CDCl3. 
    
          The single crystal X-ray structure of 13 contains a single molecule in its 
asymmetric unit and is shown in Figure 28. There is a significant deviation from planarity 
in the structure of the ligand. This deviation is evident as the interplanar dihedral angles 
formed between the benzene ring and the pyridyl and imidazole rings are 15.00 o and 
15.09 o respectively. There is an intramolecular hydrogen bonding between N(1) and H(2) 
with N(1)---H(2) distance of 1.997 Å. The ethynyl bonds are slightly distorted from 
linearity with 1.3, 5.6, 7.2, and 7.1° for angles C(5)-C(6)-C(7), C(6)-C(7)-C(8), C(13)-
C(14)-C(15), and C(14)-C(15)-C(16) respectively as shown in Figure 28. The distortion 
is more pronounced for angles C(13)-C(14)-C(15), and C(14)-C(15)-C(16). This 
distortion is due to the smaller size of the imidazole ring compared to the pyridyl ring as 
well as the intramolecular hydrogen bonding. There are several weak intermolecular 
interactions C-H---N, C-H---O and C-H---π hydrogen bonds) between molecules of 
compound 13 that help stabilize the formation of planar sheets of adjacent molecules as 
shown in Figure 29. The strong intramolecular N(1)-H(β) hydrogen bond, labelled ‘a’, 
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has a N(1)---H(2) distance of 1.999 (13) Å, that corresponds to 73% of the sum of the van 
der Waals radii of 2.75 Å. 
 
  
Figure 28. The labeled asymmetric unit of 13 showing intramolecular hydrogen bonding. 
 
 
 
Figure 29. Side-by-side projection of molecules of 13 to form planar sheets. 
                    
          A weak C-H---O hydrogen bond is also observed between the methoxy oxygen and 
the adjacent pyridine hydrogen, labelled ‘b’ in Fig. 29, with a H2A-O1 distance of 2.379 
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Å corresponding to approximately 87% of the sum of the van der Waals radii of 2.72 Å. 
There is also a nonconventional C-H---N hydrogen bond labelled ‘c’ in Fig. 29, with H9--
-N3 distance of 2.435 Å which corresponds 89% of the sum of the van der Waals radii of 
2.75 Å. We also see a weak C-H---π(C≡C) interaction between an imidazole hydrogen 
and its neighbouring alkyne pie electrons, labelled ‘x’, with H18-C6 distance of 2.772 Å, 
corresponding to approximately 96% of the sum of the van der Waals radii of 2.9 Å. The 
crystal packing features cohesive π-π interactions as can be seen in Figure 30. 
 
 
Figure 30. Three-dimensional projection of 13 showing π-π interactions, hydrogen atoms 
omitted for clarity. 
 
          The partial view of the three-dimensional packing of compound 13 clearly shows 
these π-π interactionsin (Figure 31). The overlay of the sheets is complex and the three-
dimensional packing of 13 feature two cohesive π-π interactions. There is a π-π 
interaction between two central dimethoxybenzene, labelled ‘d’ with a C1g-C1g distance 
of 3.324 Å where C1g is the centroid of the benzene ring C9-C1β. The other π-π 
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interaction is between the imidazole ring and the pyridine ring, labelled ‘e’ with a Cβg-
C3g distance of 3.343 Å, C2g and C3g are centroids of pyridine ring N4-C1-C2-C3-C4-
C5 and imidazole ring, N2-C16-N3-C17-C18 respectively. 
 
 
 Figure 31. Partial view of the three-dimensional projection of 13 viewed along b-axis. 
 
Complexation of silver(I) and palladium(II) salts by ligand 13 
Ligand 13 was designed to complex silver(I) and palladium(II) cations and we 
chose to study this binding using NMR titration. In this method, small known increments 
of the metal salts are added into a solution of the ligand and the NMR spectrum recorded 
after mixing the solution. Previous NMR titration binding studies of Pd(II) by related 
trans-coordinating bipyridyl ligands revealed that binding of Pd(II) was slow on NMR 
time scale. Accordingly, proton signals for both the bound ligand and the unbound ligand 
are observed until one equivalent of Pd(II) was added.62 Notably the pyridine protons 
signal of the complex were shifted downfield relative to the free ligand and the proton 
signal for the complex always appeared downfield.62,63 This allows for quantification of 
bound to unbound ligand by simple relative integration of bound to unbound proton 
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peaks. On the contrary, binding of silver(I) salts by related bipyridyl ligands is 
characterized by rapid exchange between complexed and un-complexed ligands. Thus, 
binding and release of silver(I) is faster than the NMR time scale. Therefore, an average 
spectrum of bound and unbound ligand is observed rather than distinct peaks 
corresponding to bound and unbound ligand. Thus, the proton chemical shift of the ligand 
protons gradually shifts downfield as the relative amount of Ag(I) is added until all the 
ligand is completely bound.62 Under certain circumstances, the relative amounts of 
complexed and un-complexed ligand can be calculated and the binding constant 
determined. 
The stoichiometry of complexation of Ag(I) by a ligand in solution can be 
determined using titration as described with a judicious, relatively high, choice of 
concentrations. The principle is that complexation of a metal cation by a ligand will result 
in a change in chemical shift of ligand protons in close proximity to the metal cation. 
When the ligand is fully bound, further addition of Ag(I) does not result in spectral 
changes. The spectra of the silver and palladium complexes were recorded in DMF-d7. 
The full 1H NMR spectra showing the ligand, the silver(I) and palladium(II) complexes 
are shown in Figure 32.  
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Figure 32. 1H NMR spectrum of ligand, silver and palladium complex in DMF-d7. 
 
Titration of ligand, 13 with silver(I) salt 
          The stoichiometry of the ligand with silver was determined by gradually titrating a 
known concentration of AgOTf against a known concentration of the ligand (in an NMR 
tube). As the silver(I) concentration increased, the chemical shift of the pyridyl protons 
shifted steadily downfield until one equivalence of the silver salt was reached as shown in 
Fig. 33, indicating that a 1:1 complex was formed between the host and the guest 
molecule. A plot of the chemical shift (∆δ) against the mole ratio of host to guest also 
clearly shows a 1:1 stoichiometry (Figure 34). It is particularly noteworthy that there was 
no further change in chemical shift after a 1:1 ratio of ligand 13 to silver(I) was reached.   
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Figure 33. Spectral changes observed in incremental addition of silver(I) 
trifluoromethane sulfonate into a dmf solution of ligand 13 (30.36 nM). 
 
The relative change in chemical shift (∆δ) for each pyridyl proton was plotted 
against the relative ratio of silver(I) to ligand 13. This plot, Figure 34, emphasizes the 1:1 
nature of the complex and the lack of secondary complexation at these concentrations of 
ligand and silver(I). These results are consistent with the reversible complexation of 
silver(I) cation that is faster than the NMR time scale. I believe that the formation of the 
silver complex takes place by initial complexation of the metal cation to the more basic 
external imidazole N of the ligand, 13 followed by rotation to afford linear complexation 
with the pyridyl nitrogen as shown in Figure 35. 
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Figure 34. Plot of the change in chemical shift ((∆δ) of pyridyl protons of ligand 13, on 
increamental addition of AgOTf. 
 
 
I hypothesized that the complexation with a monovalent cation, would lead to the 
deprotonation of the imidazole hydrogen in the presence of a weak base, for example, 
water. At this stage, I do not have enough evidence to prove that this indeed happened in 
solution. This could be proven by either dissolving the complex in basic solution, which 
would possibly effect the deprotonation of the acidic imidazole hydrogen. Furthermore, I 
was unable to isolate crystals of the silver complex suitable for single crystal X-ray 
analysis.  
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Figure 35. Proposed formation of silver complex of ligand 13. 
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Complexation of ligand, 13 with palladium(II) salt 
          The titration of ligand, 13 with palladium(II) was performed using the same 
procedure as described for Ag(I). In this experiment, we used 
bis(acetonitrile)palladium(II) dichloride as a soluble source of Pd(II). Thus, aliquots of 
PdCl2(CH3CN)2 were added into a known concentration of ligand 13 and the NMR 
spectrum recorded. On addition of 0.4 eq. of Pd(II) solution, proton signals for both Pd-
complexed and un-complexed ligand were observed. The proton signals associated with 
the un-complexed ligand diminished with simultaneous increase in the intensity of the 
proton signals associated with the Pd-complexed ligand as shown in Figure 36. The 
signal for un-complexed ligand completely disappeared when 1.0 equiv. of Pd(II) was 
added. This confirmed that the expected 1:1 complex, 13.Pd(II) was formed in solution. 
The formation of 1:1 complex, 13.PdCl2 in solution was confirmed by isolating and 
characterizing the solid from the solution obtained after NMR titration. Thus, the dmf-d7 
solution of 13.PdCl2 obtained after the titration described above was transferred into a 
vial and carefully placed into a bigger vial containing ether. After 24 h, the solvents were 
removed, and the remaining precipitate recrystallized from a mixture of dichloromethane, 
ethanol and acetonitrile. A homogeneous mass of orange crystals were harvested after 5 
days. The solid was taken for elemental analysis and the observed compositions of C, H 
and N was within ± 0.4 % of the calculated values. A single crystal suitable for X-ray 
analysis was selected and the structure determined.  
The single crystal X-ray structure of 13.PdCl2 contains a single molecule in its 
asymmetric unit. The asymmetric unit of the complex contains the ligand coordinated to 
palladium and two chloride atoms.  
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Figure 36. Stacked 1H NMR spectra obtained on sequential addition of PdCl2(CH3CN)2 
into a 75.91 nM dmf-d7 solution of 13. 
 
 
The ligand is essentially planar as shown in Figure 37. Indeed the interplanar dihedral 
angles formed between the imidazole ring and the pyridyl and benzene rings are 2.690 
(0.204)o and 1.695 (0.177)o respectively. The N(1)-Pd(1) and N(2)-Pd(1) distance are 
2.018(3)  and 2.006 (3) Å respectively while Pd(1)-Cl(1) and Pd(1)-Cl(2) distances are 
2.319 (9) and 2.334 (10) Å respectively. The coordination about palladium is square 
planar with almost linear N(1)-Pd(1)-N(2) and Cl(1)-Pd(1)-Cl(2) angle of 176.87 (12) 
and 174.40(4)o respectively. The N-Pd-Cl angles are all virtually orthogonal with N(1)-
Pd(1)-Cl(2), N(1)-Pd(1)-Cl(1), N(2)-Pd(1)-Cl(1), and N(2)-Pd(1)-Cl(2) at angles of 91.42 
(9), 89.27 (9), 91.05(9), and 89.56 (9) respectively.  The ethynyl bonds are slightly bent 
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with distortions of 5.64, 4.3, 2.3, and 4.1o for bonds C(5)-C(6)-C(7), C(6)-C(7)-C(8), 
C(13)-C(14)-C(15), and C(14)-C(15)-C(16) respectively.  
 
 
Figure 37. The labeled asymmetric unit of palladium complex of 13. 
 
The three dimensional packing of 13.PdCl2 also features multiple weak interaction: a C-
H---Cl interaction labelled ‘a’ in Figure γ8, with H-Cl distance of 2.918 Å which 
corresponds to 99% of the sum of the van der Waals radii of 3.3 Å There is a π-π 
interaction between two stacked imidazole rings, labeled ‘b’ if Figure γ8, with C4g-C4g 
distance 3.363 Å, where C4g is the centroid of the imidazole ring. There is also a 
nonconventional N-H---Cl interaction labelled ‘c’ in Fig. 38. The H-Cl distance is 2.424 
Å. A C-H---π interaction labelled ‘d’ in Figure 38, with H-Cg5 distance of 2.871 Å where 
Cg5 is the centroid of the benzene ring. Finally, a N-H---Cl interaction labelled ‘e’ in 
Figure 38, with H-Cl distance of 2.424 Å.  
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Figure 38. Partial view of the three-dimensional projection of 13.PdCl2 viewed along the 
b-axis. 
 
 
 
 
Figure 39. Side-by-side projection of complexes of 13.PdCl2 to form planar sheets. 
 
 
There is a nonconventional C-H---O hydrogen bond that helps to stabilize adjacent 
complexes to form planar sheets as shown in Figure 39. The nonconventional hydrogen 
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bond has a H17---O1 bond distance of 2.570 Å which corresponds to 94% of the sum of 
the van der Waals radii of 2.72 Å. 
 
Conclusion 
A novel ditopic ligand, 4-[(2-imidazylethynyl)]-5-(2-pyridylethynyl) veratrole 
capable of trans-coordination has been synthesized and well characterized. In a manner 
similar to 1,2-bis(β′ pyridylethynyl)benzene, this ligand also formed a trans- 1:1 complex 
with both silver(I) and palladium(II) cations. The 1:1 complex formation with both Pd(II) 
and Ag(I) was verified by elemental analysis along with NMR titration.  In addition, I 
characterized the complex formed between the ligand and palladium(II) by single crystal 
X-ray analysis. The palladium(II) complex is essentially planar and the complexation 
accorded with my initial expectations. As part of my studies, I characterized three 
iodoimidazole by X-ray crystallography. Each compound exhibited halogen bonding: one 
of the compounds, 1-benzyl-2-iodoimidazole, exhibited a strong C-I----N halogen bond 
while the other two, 1-benzyl-2-iodo-1H-benzimidazole and 1-benzyl-4-iodoimidazole, 
showed strong C-I---π bonding in addition to other weak interactions.  
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EXPERIMENTAL 
Chemicals 
Dichloromethane, hexanes, ethylacetate, iodine, sodium carbonate, ammonium 
chloride (NH4Cl), sodium bicarbonate and potassium hydroxide were purchased from 
Fisher Scientific Inc. Dichlorobis(triphenylphosphine)palladium(II) was purchased from 
Pressure Chemical Co. Tetrahydrofuran (THF), benzyl bromide, imidazole, 
benzimidazole, 2-iodoimidazole, 1,2-dimethoxybenzene (veratrole), potassium carbonate, 
silver(I) trifluoromethanesulfonate (AgOTf), anhydrous sodium sulfate (Na2SO4), 
deuterated chloroform (CDCl3), N,N-dimethylformamide (DMF), deuterated DMF, 
acetonitrile (CH3CN), copper iodide, anhydrous triethylamine, trifluoroacetic acid (TFA), 
n-butyllithium (n-BuLi) and sodium hydride (NaH) were purchased from Sigma Aldrich. 
4(5)-iodoimidazole was purchased from Alfa Aesar. Trimethylsilylacetylene was 
purchased from Matrix Scientist. Periodic acid and 2-ethynylpyridine were purchased 
from GFS chemicals. 1-(trimethylsilyl ethoxy methyl) chloride (SEMCl) was purchased 
from TCI America. Dichlorobis(acetonitrile)palladium(II) was purchased from Strem 
chemicals. Ethanol was purchased from Pharmaco-Aaper. All chemicals were used as 
received. 
 
Instrumentation 
1H and 13C NMR spectra were recorded on Varian 400 MHz Unity INOVA 
spectrometer using tetramethylsilane (TMS) as the internal standard. Melting point data 
were obtained using an SRS Digimelt MPA 160 melting point apparatus.  All elemental 
analyses were performed by Atlantic Microlab Inc. Column chromatography was carried 
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out using 230-400-mesh silica gel and used as received. For single crystal X-ray 
determination, each single crystal was mounted on a Kryoloop using a viscous paraton 
hydrocarbon oil. Data were collected using a Bruker ApexII CCD diffractometer 
equipped with Mo Kα radiation with λ = 0.7107γ Å. Data collection at 100 K was 
facilitated by use of a Kryoflex system with an accuracy of ±1 K.  Initial data processing 
was carried out using the Apex II software suite.64 Structures were solved by direct 
methods using SHELXS-2013 and refined against F2 using SHELXL-201365 with the 
program X-Seed as a graphical interface.66 For compound 13, the hydrogen atom 
involved in intramolecular hydrogen-bonding was located by difference methods and 
freely refined after initial restraint with distance N-H = 0.88 Å with Uiso(H) = -1.2 
Ueq(N). All other hydrogen atoms were not located in the difference maps but were 
placed in idealized positions and refined with a riding model. For complex 13.PdCl2, 
highly disordered solvent was removed from the refinement using the program PLATON 
SQUEEZE.67  Two voids each corresponding to 211 Å3 and 55 ē were identified. It is 
reasonable that each void corresponds to two acetonitrile molecules along with a water 
molecule.  Crystallographic details are collected in Table 3.  
 
Synthesis of 1-benzylimidazole, 1 
The titled compound was synthesized according to the procedure by Salvio et al.44 
Thus, K2CO3 (2g, 14.5 mmol) and imidazole (12.5g, 36.8 mmol) were added to a solution 
of benzyl bromide (0.9mL, 7.57mmol) in anhydrous acetonitrile (100 mL) in a 250 mL 
round bottom flask. The entire mixture was refluxed for 2 h. The reaction mixture was 
cooled, the solid was filtered off and the solvent was removed in vacuo. The residue was 
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dissolved in CH2Cl2 (100 mL) and the organic layer washed with saturated Na2CO3 
solution (50 mL x 4) and dried over Na2SO4. The solvent was removed under reduced 
pressure to give 1 as a colorless oil which crystallized into white needles after 30 mins. 
(1.20 g, 93% yield). Mp: 69-72 oC. 1H NMR (400 MHz, CDCl3): δ 7.54 (s, 1 H), 7.γβ-
7.35 (m, 3 H), 7.13-7.16 (m, 2 H), 7.09 (s, 1 H), 6.90 (s, 1 H), 5.11 (s, 2 H).  
 
Synthesis of 1-benzyl-2-iodo-1H-imidazole, 2 
1-benzyl-1H-imidazole (2 g, 12.64 mmol) and anhydrous THF (35 mL) were 
combined in a 3-necked 250 mL round bottom flask under argon. The mixture was 
cooled to -78 oC and stirred at this temperature for 7 mins. n-Butyllithium (1.6 M, 8 mL, 
12.64 mmol, 1 equiv.) was added dropwise over 2 mins and the resultant mixture stirred 
at -78 oC for 45 mins. Iodine (4.81 g, 18.96 mmol, 1.5 equiv.) was crushed and added into 
the stirred mixture. The cooling bath was removed and the mixture stirred at room 
temperature for 3 h under argon. The mixture was extracted with CH2Cl2 (300 mL) and 
excess I2 quenched with 10% Na2SO3 (200 mL). The organic layer was separated, 
washed twice with H2O (200 mL) and twice with brine (200 mL) and then dried over 
Na2SO4. The solvent was removed in vacuo and the crude product purified by flash 
column chromatography with a 10:1 mixture of hexane and ethyl acetate as the eluent to 
afford 2 as a white solid (2.23 g, 62%) The solid was recrystallized from a 9:1 mixture of 
hexane and ethyl acetate as white needle-like crystals.  Rf = 0.27 [Hexane/EtOAc (2:1)]. 
Mp: 100.5-102.9 ̊C. 1H NMR (400 MHz, CDCl3): 7.32-7.38 (m, 3 H), 7.12-7.15 (m, 3 H), 
7.01 (d, 3J = 1.6 Hz, 1 H), 5.10 (s, 2 H). 
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Synthesis of 1-benzyl-1H-benzimidazole, 3 
A suspension of NaH (60% in mineral oil, 1.53 g, 37.71 mmol) in hexane (20 mL) 
was stirred under argon for 5 mins. After removal of the supernatant solution, anhydrous 
THF (20 mL) was then added. The mixture was cooled to 0 oC and a solution of 
benzimidazole (3.6 g, 30.47 mmol) in THF (24 mL) was added to the resulting NaH 
suspension and the mixture stirred at room temperature for 40 mins. The mixture was 
again cooled to 0 oC, followed by addition of benzyl bromide (3.8 mL, 5.47 g, 31.99 
mmol). The entire mixture was stirred at 0 oC for 20 mins and then at room temperature 
for 15 mins. The reaction was quenched with saturated NH4Cl (40 mL) and the solvent 
removed under reduced pressure. The residue was extracted with CH2Cl2 (2 x 40 mL), 
subsequently washed with H20 (20 mL), brine (20 mL), dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography with a mixture of 10:1 hexane and ethylacetate as the eluent. The 
product was isolated as an off-white solid (4.64g, 72%) which was then recrystallized 
from 3:2 hexane/EtOAc mixture. Rf = 0.45 [hexane/EtOAc 1:1)].   Mp: 116.5-117.8oC. 
1H NMR (400 MHz, CDCl3) δ: 7.95 (s, 1H), 7.83 (d, 3J = 8.4 Hz, 1 H), 7.35-7.23 (m, 6 
H), 7.18 (d, 3J = 6.4 Hz, 2 H), 5.36 (s, 2 H).  
 
Synthesis of 1-benzyl-2-iodo-1H-benzimidazole, 4  
1-benzyl-1H-benzimidazole (4 g, 19.21 mmol) and anhydrous THF (60 mL) were 
combined in a flask under argon. The mixture was cooled to -78 oC and stirred at this 
temperature for 10 mins. n-Butyllithium (1.6 M, 12 mL, 19.21 mmol, 1 equiv.) was 
added slowly over 2 mins. The mixture was left to stir at -78 oC for 45 mins. I2 (7.31 g, 
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28.81 mmol, 1.5 equiv.) was crushed and added into the mixture. The entire mixture was 
stirred at room temperature for 3 h under argon. The mixture was then extracted with 
CH2Cl2 (300 mL) and excess I2 was quenched with 10% Na2SO3 (200 mL). The organic 
layer was washed with H2O (200 mL), brine (100 mL x 2), and dried over Na2SO4. The 
solvent was removed in vacuo and the crude product purified by flash column 
chromatography with a 10:1 mixture of hexane and ethylacetate as the eluent. The 
product was isolated as a white solid (3.51g, 54%). This solid was then recrystallized 
from (hexane/EtOAc: 3/2) to afford white crystals. Rf = 0.81 [Hexane/EtOAc (1:1)]. Mp: 
121-122oC. 1H NMR (400 MHz, CDCl3) δ: 7.76 (dt, 3J = 7.8 Hz, 4J = 1.2 Hz, 1 H), 7.34-
7.13 (m, 1 H), 7.35-7.23 (m, 8 H), 5.36 (s, 2 H).  
 
Synthesis of 1-benzyl-4-iodo-1H-imidazole, 5  
A suspension of NaH (60% in mineral oil, 0.401 g, 10.0 mmol) in hexane (8 mL) 
was stirred under argon for 5 mins. After removal of the supernatant solution, anhydrous 
THF (10 mL) was then added. The mixture was cooled to 0 oC and a solution of 4(5)-
iodo-1H-imidazole (1.48 g, 7.64 mmol) in THF (7 mL) was added to the resulting NaH 
suspension. The entire mixture was stirred at room temperature for 40 mins. The mixture 
was again cooled to 0 oC, followed by addition of benzyl bromide (0.95 mL, 1.37 g, 7.99 
mmol). The entire mixture was again stirred at 0 oC for 20 mins and at room temperature 
for another 20 mins. The reaction was quenched with saturated NH4Cl (30 mL) and 
solvent removed in vacuo. The residue was extracted with CH2Cl2 (2 x 50 mL), and the 
solution was subsequently washed with H20 (60 mL), brine (100 mL), and dried over 
Na2SO4. The solvent was removed in vacuo and the product obtained as a yellow oil 
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(2.54 g, 100 %).  The crude product was isomerized by reaction with a slight excess of 
benzyl bromide.  Thus 2.54 g of the product was dissolved in DMF (20 mL) and benzyl 
bromide (0.1 mL, 10 mol%) was added. The mixture was stirred at 75 oC for 24 h. The 
reaction was quenched with H2O (2 mL), and dissolved in CH2CL2 (200 mL). DMF was 
removed by washing the organic layer with H2O (7 x 200 mL). The organic layer was 
separated, dried over Na2SO4 and the solvent removed in vacuo. The product was 
recrystallized from (CH3CN/EtOH: 1:2) to give yellow crystals.  Mp: 97-102 ̊C. 1H NMR 
(400 MHz, CDCl3) δ: 7.44 (s, 1 H), 7.γ4-7.38 (m, 3 H), 7.17 (dd, 3J = 7.8 Hz, 4J = 2.0 
Hz, 2 H), 6.97 (s, 1 H), 5.08 (s, 2H).  
 
Synthesis of 1-[[2-(trimethylsilyl)ethoxy]methyl]-imidazole, 6 
 A suspension of NaH (60% in mineral oil, 0.68 g, 16.94 mmol) in hexane (15 
mL) was stirred under argon for 5 mins. After removal of the supernatant solution, 
anhydrous THF (14 mL) was then added. The mixture was cooled to 0 oC and a solution 
of imidazole (1.058 g, 15.4 mmol) in THF (6 mL) was added to the resulting NaH 
suspension. The mixture was then stirred at 0 oC for 5 mins and then at room temperature 
for 30 mins. The mixture was again cooled to 0 oC, followed by addition of 1-
(trimethylsilylethoxy methyl) chloride (2.86 mL, 16.17 mmol 1.05 eq.). The entire 
mixture was stirred at 0 oC for 30 mins. The reaction was then quenched with saturated 
NH4Cl (50 mL) and THF was removed under reduced pressure. The residue was 
extracted with CH2Cl2 (50 mL x 5), and subsequently washed with H2O (60 mL) and 
brine (60 mL). The organic layer was then dried over Na2SO4 and the solvent removed 
under reduced pressure. The product was obtained as a colorless oil (3.25 g, 100%).  1H 
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NMR (400 MHz, CDCl3): δ 7.48 (s, 1 H), 6.94 (d, 3J = 11.6 Hz, 1 H), 5.15 (s, 2 H), 3.35 
(t, 3J = 8.4 Hz, 2 H), 0.87 (t, 3J = 8.4 Hz, 2 H), -0.14 (s, 9 H).   
 
Synthesis of 1-[[2-(trimethylsilyl)ethoxy]methyl]-2-iodoimidazole, 7 
1-[[2-(Trimethylsilyl)ethoxy]methyl]-imidazole  (3 g, 15.46 mmol) and 
anhydrous THF (30 mL) were combined in a flame dried flask under argon. The mixture 
was cooled to -78 oC and stirred at this temperature for 10 mins. n-Butyllithium (1.6 M, 
11.4 mL, 18.23 mmol, 1.2 equiv.) was added slowly over 2 mins. The mixture was stirred 
at -78 oC for 1 h. I2 (4.95 g, 19.64 mmol, 1.5 equiv.) was crushed and added into the 
mixture, and the entire mixture was then stirred at room temperature for 3 h under argon. 
The mixture was extracted with CH2Cl2 (100 mL) and excess I2 was quenched with 10% 
Na2SO3 (200 mL). The organic layer was separated, washed with H2O (200 mL), brine 
(100 mL x 2), and dried over Na2SO4. The solvent was removed in vacuo and the crude 
product purified by flash column chromatography with a 10:1 mixture of ethylacetate and 
hexane as the eluent. The product was obtained as a yellow oil (2.75 g, 56%). Rf = 0.4 
[Hexane/EtOAc (2:1)]. 1H NMR (400 MHz, CDCl3): δ 7.11 (d, 3J = 1.6 Hz, 1 H), 7.068 
(d, 3J = 0.8 Hz, 1 H), 5.18 (s, 2 H), 3.48 (t, 3J = 8.4 Hz, 2 H), 0.87 (t, 3J = 8.4 Hz, 2 H), -
0.06 (s, 9 H). 13C NMR (100 MHz, CDCl3): δ 1γγ.1, 1βγ.5, 110.9, 7β.7, 66.7, 17.9, -1.2.  
 
Synthesis of 1-[[2-(trimethylsilyl)ethoxy]methyl]-2-[2 
(trimethylsilyl)ethynyl]imidazole, 8 
1-[[2-(Trimethylsilyl)ethoxy]methyl]-2-iodoimidazole (2 g, 6.17 mmol) and 
triethylamine (15 mL) were added to a pressure flask under argon. PdCl2(PPh3)2 (100 mg, 
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0.14 mmol), copper iodide (45 mg, 0.24 mmol) and trimethylsilyl acetylene (1.77 g, 2.5 
mL, 18.20 mmol) were then added into the flask. Argon flow was removed and the 
pressure flask sealed. The mixture was heated to 60 oC for 40 h. The reaction mixture was 
then cooled to room temperature and the solvent was removed in vacuo. The residue was 
dissolve in CH2Cl2 (100 mL), washed with brine (80 mL x 2) and dried over Na2SO4. The 
solvent was again removed under reduced pressure, and the crude product purified by 
flash column chromatography with a mixture of 20:1 hexane and ethylacetate as the 
eluent. The product was obtained as a yellow oil (0.812 g, 44%). Rf = 0.3 [EtOAc/hexane 
(2:1)]. 1H NMR (400 MHz, CDCl3): δ 7.04 (d, 3J = 3.2 Hz, 2 H), 5.34 (s, 2 H), 3.43 (t, 3J 
= 8.4 Hz, 2 H), 0.87 (t, 3J = 8.4 Hz, 2 H), - 0.12 (s, 9 H), -0.06 (s, 9 H). 
 
Synthesis of 1-{[2-(trimethylsilyl)ethoxy]methyl}-2-ethynylimidazole, 9 
A solution of potassium hydroxide (0.3 g, 5.35 mmol) in water (0.5 mL) was 
added to a solution of compound 8 (0.812g, 2.72 mmol) in ethanol (10 mL) in a round 
bottom flask. The mixture was stirred at room temperature and the reaction monitored by 
TLC. After 2 h, the solvent was evaporated, and the residue was dissolved in CH2Cl2 (60 
mL), washed with brine (50 mL x 2) and dried over Na2SO4. The solvent was remove in 
vacuo and the crude product purified by flash column chromatography with a mixture of 
10:1 hexane and ethylacetate as the eluent. The product was obtained as a yellow oil 
(0.390 g, 65%). Rf  = 0.3 [hexane/EtOAc (2:1)]. 1H NMR (400 MHz, CDCl3): δ 7.05 (d, 
3J = 3.2 Hz, 2 H), 5.37 (s, 2 H), 3.50 (t, 3J = 8.4 Hz, 2 H), 3.32(s, 1 H), 0.87 (t, 3J = 8.4 
Hz, 2 H), -0.06 (s, 9 H). 13C NMR (100 MHz, CDCl3): δ 1γ1.1, 1γ0.1, 1β0.5, 88.5, 81.5, 
75.2, 72.9, 66.5, 17.6, -1.5. 
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Synthesis of 1,2-diiodo-4,5-dimethoxy benzene (1,2-diiodo veratrole), 10 
Periodic acid (5.84 g, 25.6 mmol, 0.41 equiv.) and methanol (36 mL) were 
combined in a flame dried 100 mL round bottom flask. Iodine (12.86 g, 51.0 mmol, 0.8 
equiv.) was then added and the mixture was stirred for 10 mins. 1,2-dimethoxybenzene 
(veratrole) (7.9 mL, 8.57 g, 62.0 mmol) was then added into the reaction mixture and it 
was heated to 70 oC for 5 h. The mixture gradually changed from an orange solution to a 
cloudy solution. The hot solution was poured into a 5% solution of sodium sulfite (100 
mL). The solid was filtered off and washed quickly with cold methanol (30 mL x 2). The 
solid residue obtained, was dried overnight in the fume hood. The product (21.92 g, 91%) 
was then recrystallized from 2:1 mixture of hexane and ethyl acetate to give pure white 
crystals. Mp: 134-136 oC. 1H NMR (400 MHz, CDCl3): δ 7.β4 (s, β H), 3.84 (s, 6 H). 13C 
NMR (100 MHz, CDCl3): δ 149.7, 1β1.8, 96.β, 56.γ. 
 
Synthesis of 4-iodo-5-(2-ethynylpyridine) veratrole, 11  
 1,2-diiodo veratrole (5.00 g, 12.8 mmol), PdCl2(PPh3)2 (0.100 g, 0.14 mmol), CuI 
(0.092 g, 0.49 mmol), 2-ethynylpyridine (0.7 ml, 0.660 g, 6.4 mmol), THF (30 mL) and 
triethylamine (10 mL) were reacted under argon atmosphere at room temperature for 4 
days. The mixture was diluted with ethyl acetate (200 mL) and washed with water (100 
mL x 3) followed by brine (100 mL x 3).  The organic layer was separated, dried over 
Na2SO4, filtered and solvent removed in vacuo. The crude solid was purified by flash 
column chromatography with a 5:1 mixture of hexane and ethylacetate as the eluent. The 
product was obtained as a brown oil which solidified after 2 days (1.44, 3.94 mmol, 
62%). Rf  = 0.27 [EtOAc/hexane (2:1)]. Mp: 89.5-90.1 oC.  1H NMR (400 MHz, CDCl3): 
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δ = 8.64 (d, 3J = 4.8 Hz, 1 H), 7.74 (td, 3J = 7.8 Hz, 4J = 2.0 Hz, 1 H), 7.64 (d, 3J = 7.8 
Hz, 1 H), 7.28 (m, 2 H), 7.26 (s, 1 H), 3.90 (s, 3 H), 3.88 (s, 3 H). 13C NMR (100 MHz, 
CDCl3): δ = 150.5, 149.8, 149.β, 14γ.β, 1γ6.8, 1β7.6, 1βγ.1, 1β1.1, 1β1.0, 115.6, 9β.5, 
90.6, 90.2, 56.4, 56.3. 1,2-Bis(2-pyridylethynyl) veratrole was also isolated as a brown 
solid (0.612 g, 1.8 mmol, 26%). 
 
Synthesis of 4-[1-(2-trimethylsilylethoxymethyl)]-1H-imidazylethynyl [5-
(2pyridylethynyl)] veratrole, 12 
Compound 9 (0.41 g, 1.85 mmol) and compound 11, (1.24 g, 3.38 mmol) were 
reacted in triethylamine (3 mL) and THF (5 mL) with PdCl2(PPh3)2 (100 mg, 0.14 mmol) 
and CuI (45 mg, 0.24 mmol) as the catalyst under argon at 60 oC for 24 h. The mixture 
was cooled to room temperature, diluted with CH2Cl2 (100 mL) and washed with brine 
(50 mL x 2). The organic layer was separated, dried over Na2SO4, and solvent removed in 
vacuo. The crude product was purified by flash column chromatography with a 1:1 
mixture of hexane and ethylacetate as the eluent. The product was obtained as a red oil, 
which solidified after 5 days (0.3895 g, 46%). Rf = 0.30 [EtOAc/hexane (2:/1)].  Mp: 
110.8-111.9 oC. 1H NMR (400 MHz, CDCl3): δ 8.65 (d, 3J = 4.8 Hz, 1 H), 7.66 (td, 3J = 
7.8 Hz, 4J = 2.0, Hz, 1 H), 7. 55 (d, 3J = 7.8 Hz, 1 H), 7.23 (ddd, 3J = 7.8 Hz, 5.0 Hz, 4J = 
1.2 Hz, 5J = 1.2 Hz, 1 H), 7.18 (s, 1 H), 7.08 (d, 3J = 1.2 Hz, 3 H), 5.52 (s, 2 H), 3.89 (s, 6 
H, OCH3), 3.49 (t, 3J = 8.4Hz, 2 H), 0.76 (t, 3J = 8.4 Hz, 2 H), -0.15 (s, 9 H). 13 C NMR 
(100 MHz, CDCl3): δ = 150.β, 149.8, 149.7, 14γ.γ, 1γ6.γ, 1γβ.5, 1γ0.7, 1β7.γ, 1βγ.0, 
120.3, 117.7, 117.6, 114.7, 114.3, 91.7, 91.6, 88.1, 81.5, 75.6, 66.6, 56.2, 17.7, -1.4. 
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Synthesis of 4-[(2-imidazylethynyl)]-5-(2-pyridylethynyl) veratrole, 13 
Trifluoroacetic acid (4.3 mL) was added to a solution of 12 (100 mg, 0.27 mmol) 
in THF (0.6 mL). The mixture was stirred at room temperature and monitored by TLC. 
After 7 h, trifluoroacetic acid was removed in vacuo and the crude product dissolved in 
CH2Cl2 (50 mL). Residual acid was neutralized by stirring the mixture in a saturated 
solution of NaHCO3 (10 mL). The organic layer was separated, washed with brine (40 
mL), and dried over Na2SO4. The solvent was removed under reduced pressure and the 
crude product was then purified by preparative-TLC with a 5:1 mixture of ethylacetate/ 
hexane (Rf = 0.45). The product was isolated as a brown solid (36 mg, 0.11 mmol, 50%) 
and recrystallized from a 1:1 mixture of acetonitrile and dichloromethane to afford brown 
crystals and the crystal structure was determined by Dr. Eric Bosch. Mp: 185.1-186.9 oC. 
1H NMR (400 MHz, CDCl3): δ 8.58 (d, 3J = 4.4 Hz, 1 H), 7.74 (td, 3J = 7.8 Hz, 4J = 1.6 
Hz, 1 H), 7. 55 (d, 3J = 7.8 Hz, 1 H), 7.30 (ddd, 3J = 7.6 Hz, 4J = 4.8 Hz, 5J = 1.2 Hz, 1 
H), 7.15 (s, 2 H), 7.02 (d, 3J = 2.0 Hz, 2 H), 3.90 (s, 3 H), 3.89 (s, 3 H). 13C NMR (100 
MHz, CDCl3): δ 150.β, 149.4, 149.β, 14γ.0, 1γ7.γ, 1γ1.0, 1β7.β, 1βγ.β, 1β0.1, 118.0, 
113.5, 112.6, 91.8, 90.0, 89.0, 85.4, 56.3. Anal. Calcd. for C20H15N3O2: C, 72.94; H, 4.59; 
N, 12.76. Found: C, 72.74; H, 4.52; N, 12.63. 
 
Synthesis of {4-[(2-imidazylethynyl)]-5-(2-pyridylethynyl) veratrole} silver 
trifluoroacetate 
The ligand, 13 (0.0030 g, 0.0091 mmol) was dissolved in CH3CN (2 mL), and the 
solution was combined with a separate solution of CF3COOAg (0.0024 g, 0.0091 mmol) 
CH3CN (0.3 mL) in a vial. The vial was loosely capped and placed in the fume hood. 
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After 10 days, colorless crystals were harvested (1.8 mg, 35%). 1H NMR (400 MHz, 
DMF-d7): δ 8.58 (dt, 3J = 5.2 Hz, 4J = 0.8 Hz, 1 H), 8.26 (td, 3J = 7.8 Hz, 4J = 1.6 Hz, 1 
H), 8.05 (s, 1H), 7.79 (ddd, 3J = 7.6 Hz, 4J = 5.1 Hz, 5J = 1.6 Hz, 1 H), 7.71 (s, 1 H), 7.54 
(s, 1 H), 7.29 (s, 1 H), 7.19 (s, 1 H), 4.00 (s, 3H, OCH3), 3.99 (s, 3H, OCH3). Anal. 
Calcd. for C22H15AgF3N3O4.H2O: C, 46.50; H, 2.87; N, 7.13. Found: C, 46.50; H, 3.02; 
N, 7.39. 
 
Synthesis of {4-[(2-imidazylethynyl)]-5-(2-pyridylethynyl) veratrole} palladium (II) 
dichloride 
The ligand, 13 (0.0030 g, 0.0091 mmol) was dissolved in anhydrous CH3CN (2 
mL), and the solution was added to a separate solution of PdCl2(CH3CN)2 (0.0024 g, 
0.0091 mmol) in CH3CN (0.3 mL) in a vial. The vial was capped and placed in the hood. 
Yellow crystals were harvested after 5 days (2.2 mg, 54 %) and the crystal structure was 
solver by Dr. Eric Bosch. 1H NMR (400 MHz, DMF-d7): δ 8.58 (d, 1 H), 8.06 (td, 3J = 
7.8 Hz, 4J = 1.6 Hz, 1 H), 7. 87 (d, 3J = 7.8 Hz, 1 H), 7.62 (m, 1 H), 7.54 (m, 2H) 7.27 (t, 
3J = 1.56 Hz, 1 H), 7.24 (s, 1 H), 4.03 (s, 3H, OCH3), 4.02 (s, 3H, OCH3). Anal. Calcd. 
for C20H15Cl2N3O2Pd: C, 47.41; H, 2.98; N, 8.29. Found: C, 47.26; H, 3.14; N, 8.49. 
 
Titration of ligand,13 with silver(I) triflate 
A solution of ligand, 13 (9 mg, 0.027 mmol) in DMF-d7 (0.9 mL, 30.36 mM) was 
carefully transferred into a clean and dry NMR tube. A solution of CF3SO3Ag was then 
prepared in a vial by dissolving CF3SO3Ag (78 mg, 0.30 mmol) in DMF-d7 (0.9 mL, 
337.29 mM).  Thereafter, the 1H NMR spectrum of the ligand was collected and then the 
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titration begun. 10 µL aliquot of the CF3SO3Ag solution was added to the NMR tube 
containing the ligand. The mixture was vortexed to ensure homogeneity and the 1H NMR 
spectrum collected at 32 scans. Injection of 10 µL of CF3SO3Ag into the tube and 
collection of 1H NMR spectrum continued until no significant change in the chemical 
shift of the ligand protons were observed (150 µL was added in total).  
 
Titration of ligand, 13 with bis(acetonitrile)palladium(II) dichloride 
A solution of ligand, 13 (9 mg, 0.027 mmol) in DMF-d7 (0.9 mL, 75.71 mM) was 
carefully transferred into a clean and dry NMR tube. A solution of PdCl2(CH3CN)2 was 
then prepared in a vial by dissolving PdCl2(CH3CN)2 (78 mg, 0.30 mmol) in DMF-d7 (0.9 
mL, 759.04 mM).  Thereafter, the 1H NMR spectrum of the ligand was collected and then 
the titration begun. 20 µL aliquot of the PdCl2(CH3CN)2 solution was added to the NMR 
tube containing the ligand. The mixture was vortexed to ensure homogeneity and the 1H 
NMR spectrum collected at 32 scans. Injection of 20 µL into the tube and collection of 
1H NMR spectrum continued until proton peaks associated with the ligand protons 
completely disappeared (100 µL was added in total). 
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APPENDICES 
 
 
Appendix A: Crystal data for studied compounds 
 
Appendix A-1. Selected bond distances and angles for compounds 2, 4, 5, 13 and  
13.PdCl2 
 
  Compound 2  
Bong Distances (Å) 
N1---I1 
 
2.877 (2) 
 
C1---I1 
 
2.088 (3) 
N1---C4 1.461 (4) C7-H4 0.9500 
C6---C4 1.512 (4) C1-N2 1.357 (4) 
Bond Angles (deg) 
C1-I1-N2 174.42(9) C1-N1-C3 106.4 (2) 
H2-C8-C9 120.2 N2-C2-C3 110.5 (2) 
  Compound 4  
Bond Distances(Å)    
I1---C1 2.079 (16) N1---C8 1.459 
NI---C1 1.372 (2) C5-H5 0.95 
C9---C14 1.392 C8---H8B 0.99 
 
Bond Angles (deg) 
   
C1-N1-C7 105.30(13) C1-N2-C3 103.99 (14) 
N1-C8-H8B 109.1 C12-C11-C10 120.19 (16) 
  Compound 5  
Bond Distances (Å)    
I1---C2 2.0717 (18) N1---C4 1.467 (2) 
C6---C7 1.388 (30 C10---H10 0.95 
 
Bond Angles (deg) 
   
N2-C1-N1 112.62 (16) N1-C3-H3 127.4 
N2-C1-H1 123.7 C2-C3-H3 127.4 
C3-C2-N2 111.35 (16) N1-C4-H4B 109.0 
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Appendix A-1, cont. 
 
  Compound 13  
Bond Distances (Å)    
O1---C10 1.360 (4) C5---C6 1.440 (4) 
C1---H1 0.95 C9---C10 1.393 (4) 
C5---N1 1.360 (4) N3---C16 1.331 (4) 
 
Bond Angles (deg)    
C2-C3-H3 120.4 N3-C18-H18 110.8 (3) 
C5-C6-C7 178.7 (3) C6-C7-C8 174.4 (3) 
C13-C14-C15 172.8 (3) C14-C15-C16 172.9 (3) 
  Compound 
13.PdCl2  
Bond Distances    
Pd1---N1 2.018 (3) Pd1---Cl1 2.3185 (9) 
Pd1---Cl2 2.3336 (10) Pd1-N2 2.006 (3) 
Bond Angles (deg)    
N11-Pd1-Cl1 89.27 (9) N1-Pd1-Cl2 90.42 (9) 
N2-Pd1-Cl1 91.05 (9) N2-Pd1-Cl2 89.56 (9) 
N2-Pd1-N1 176.87 (12) Cl1-Pd1-Cl2 174.40 (4) 
C5-C6-C7 174.4 (4) C6-C7-C8 175.7 (4) 
C13-C14-C15 177.9 (4) C14-C15-C16 175.9 (4) 
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Appendix A-2. Crystallographic data for compounds 2, 4, and 5 
 
 Compound 2 Compound 4 Compound 5 
Formula C10H9IN2 C10H9IN2 C14H11IN2 
Formula weight 284.09 284.09 334.15 
Crystal dim. (mm3) 0.30 x 0.20 x 0.05 0.22 x 0.22 x 0.22 0.22 x 0.22 x 0.22 
Crystal system,  Orthorhombic  Monoclinic Triclinic 
Crystal color colorless Colorless Colorless 
space group P212121 P21/n P 1¯ 
a, b, c (Å) 8.7561 (5), 9.0016 (5), 12.8869 (7) 
8.4574 (5), 6.1526 
(3), 19.4261 (10) 
6.4606 (8), 8.2346 (10), 
12.3451 (14) 
α, ȕ, Ȗ (°) 90, 90, 90 90, 96.362 (1), 90 108.064 (1), 94.174 (2), 95.366 (2) 
V (Å3) 1015.73 (10) 1004.61 (9) 618.05 (13) 
Z 4 4 2 
ρcalcd (mg m-3) 1.858 1.796 1.878 
T(K) 100 100 100 
µ (mm-1) 3.11 3.14 2.57 
Reflections/unique  13262/2228 12374/2207 8079/2777 
Data/parameters/ 
restraints 2228/118/0 2207/118/0 2777/154/0 
Rint 0.030 0.021 0.016 
Goodness of fit 1.052 1.105 1.090 
R1/wR2 0.013/0.030 0.016/0.037 0.015/0.039 
R1/wR2 (all data) 0.013/0.030 0.017/0.037 0.016/0.039 
Largest diff. 
peak/hole/eÅ3 0.25/-0.27 0.73/-0.52 0.74/-0.35 
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Appendix A-3. Crystallographic data for compound 13 and complex 13.PdCl2 
 
 
 
 
Compound 13 
 
Complex 13.PdCl2    
Formula C20H15N3O2  C20H15Cl2N3O2Pd    
Formula weight 329.35  506.65    
Crystal dim. (mm3) 0.25 x 0.21 x 0.02  0.20 x 0.15 x 0.02    
Crystal system Triclinic Monoclinic    
Crystal color Gold Gold    
Space group P-1  P 21/c    
a (Ǻ) 698 (3)  11.1420 (7)    
b (Ǻ) 9.659 (4)  27.3615 (17)    
c (Ǻ) 13.379 (6)  7.4271 (5)    
α (deg) 110.387 (6), 90    
ȕ (deg) 95.185 (6), 95.878 (1)    
Ȗ (deg) 92.835 (7) 90     
Z 2 4    
V (Ǻ3) 804.9 (6) 2252.3 (3)    
ρcalcd (mg m-3) 1.359 1.494    
T (K) 100 100    
µ (mm-1) 0.090 1.080    
Reflections/unique 10259/3576 28387/5039    
Data/ 
parameters/restraints 3576/231/1 5039/258/0    
Rint 0.059 0.041    
Goodness of fit 0.992 1.147    
R1/wR2 0.065/0.166 0.045/0.100    
R1/wR2 (all data) 0.128/0.209 0.051 / 0.1021    
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Appendix A-4. Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) for compound 2 
 
 x Y z Uiso*/Ueq  
I1 0.23697 (2) 0.28234 (2) 0.52915 (2) 0.01308 (5)  
N1 0.1137 (3) 0.4336 (3) 0.72457 (18) 0.0140 (5)  
C1 0.0779 (3) 0.3510 (3) 0.6399 (2) 0.0126 (6)  
N2 −0.0686 (γ) 0.3169 (3) 0.63687 (19) 0.0153 (5)  
C2 −0.1β94 (γ) 0.3814 (3) 0.7256 (2) 0.0175 (6)  
H1 −0.βγγ7 0.3759 0.7456 0.021*  
C3 −0.0β0γ (γ) 0.4526 (3) 0.7792 (2) 0.0173 (6)  
H9 −0.0γβ9 0.5057 0.8423 0.021*  
C4 0.2632 (4) 0.4913 (3) 0.7544 (2) 0.0163 (6)  
H7 0.2484 0.5859 0.7923 0.020*  
H8 0.3218 0.5138 0.6906 0.020*  
C5 0.3573 (3) 0.3881 (3) 0.8214 (2) 0.0145 (6)  
C6 0.3217 (3) 0.2395 (3) 0.8364 (2) 0.0165 (6)  
H3 0.2345 0.1980 0.8035 0.020*  
C7 0.4136 (3) 0.1504 (4) 0.8995 (2) 0.0210 (7)  
H4 0.3885 0.0487 0.9094 0.025*  
C8 0.5407 (3) 0.2094 (4) 0.9477 (2) 0.0215 (7)  
H2 0.6027 0.1487 0.9909 0.026*  
C9 0.5776 (4) 0.3587 (4) 0.9327 (2) 0.0222 (7)  
H5 0.6647 0.4001 0.9658 0.027*  
C10 0.4869 (3) 0.4463 (3) 0.8693 (2) 0.0177 (6)  
H6 0.5134 0.5474 0.8583 0.021*  
 
 
Appendix A-5. Atomic displacement parameters (Å2) for compound 2 
 
 U11 U22 U33 U12 U13 U23 
I1 0.01264 (8) 0.01415 (9) 0.01244 (8) 0.00140 (7) 0.00028 (7) −0.000β0 (6) 
N1 0.0139 (12) 0.0132 (12) 0.0150 (12) 0.0009 (10) −0.0017 (10) −0.0015 (10) 
C1 0.0138 (14) 0.0102 (13) 0.0138 (14) 0.0027 (11) −0.000β (11) 0.0008 (11) 
N2 0.0134 (11) 0.0163 (14) 0.0161 (12) 0.0017 (9) −0.0001 (9) 0.0000 (9) 
C2 0.0153 (14) 0.0183 (16) 0.0189 (15) 0.0027 (12) 0.0024 (12) −0.0005 (1β) 
C3 0.0206 (16) 0.0178 (15) 0.0135 (14) 0.0043 (13) 0.0023 (13) −0.0010 (1β) 
C4 0.0169 (14) 0.0147 (13) 0.0172 (12) −0.00γ6 (1β) −0.00γβ (15) −0.0006 (10) 
C6 0.0148 (13) 0.0173 (16) 0.0174 (13) −0.0015 (11) −0.000γ (11) −0.0018 (1β) 
C7 0.0222 (16) 0.0204 (15) 0.0203 (15) 0.0022 (13) 0.0067 (13) 0.0026 (13) 
C8 0.0211 (14) 0.0277 (17) 0.0156 (14) 0.0087 (15) −0.0008 (11) 0.0024 (14) 
C9 0.0171 (15) 0.0285 (18) 0.0210 (16) 0.0039 (14) −0.00γ4 (1β) −0.00γ9 (14) 
C0 0.0169 (15) 0.0168 (15) 0.0195 (15) −0.0010 (1β) 0.0007 (13) −0.00γ7 (1γ) 
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Appendix A-6. Geometric parameters (Å, º) for compound 2 
 
I1—C1 2.088 (3) C5—C6 1.387 (4) 
N1—C1 1.357 (4) C5—C10 1.394 (4) 
N1—C3 1.379 (3) C6—C7 1.397 (4) 
N1—C4 1.461 (4) C6—H3 0.9500 
C1—N2 1.319 (3) C7—C8 1.381 (4) 
N2—C2 1.389 (4) C7—H4 0.9500 
C2—C3 1.341 (4) C8—C9 1.395 (5) 
C2—H1 0.9500 C8—H2 0.9500 
C3—H9 0.9500 C9—C10 1.386 (4) 
C4—C5 1.512 (4) C9—H5 0.9500 
C4—H7 0.9900 C10—H6 0.9500 
C4—H8 0.9900   
C1—N1—C3 106.4 (2) C6—C5—C10 118.9 (3) 
C1—N1—C4 127.8 (2) C6—C5—C4 123.4 (3) 
C3—N1—C4 125.8 (2) C10—C5—C4 117.7 (3) 
N2—C1—N1 112.1 (2) C5—C6—C7 120.4 (3) 
N2—C1—I1 124.0 (2) C5—C6—H3 119.8 
N1—C1—I1 123.9 (2) C7—C6—H3 119.8 
C1—N2—C2 104.5 (2) C8—C7—C6 120.3 (3) 
C3—C2—N2 110.5 (3) C8—C7—H4 119.8 
C3—C2—H1 124.7 C6—C7—H4 119.8 
N2—C2—H1 124.7 C7—C8—C9 119.7 (3) 
C2—C3—N1 106.5 (3) C7—C8—H2 120.2 
C2—C3—H9 126.8 C9—C8—H2 120.2 
N1—C3—H9 126.8 C10—C9—C8 119.8 (3) 
N1—C4—C5 114.8 (2) C10—C9—H5 120.1 
N1—C4—H7 108.6 C8—C9—H5 120.1 
C5—C4—H7 108.6 C9—C10—C5 120.9 (3) 
N1—C4—H8 108.6 C9—C10—H6 119.5 
C5—C4—H8 108.6 C5—C10—H6 119.5 
H7—C4—H8 107.5   
C3—N1—C1—N2 0.2 (3) C3—N1—C4—C5 90.2 (3) 
C4—N1—C1—N2 179.7 (2) N1—C4—C5—C6 13.0 (4) 
C3—N1—C1—I1 −178.7 (β) N1—C4—C5—C10 −167.7 (β) 
C4—N1—C1—I1 0.9 (4) C10—C5—C6—C7 0.8 (4) 
N1—C1—N2—C2 −0.γ (γ) C4—C5—C6—C7 −179.9 (γ) 
I1—C1—N2—C2 178.5 (2) C5—C6—C7—C8 0.0 (4) 
C1—N2—C2—C3 0.3 (3) C6—C7—C8—C9 −0.γ (4) 
N2—C2—C3—N1 −0.β (γ) C7—C8—C9—C10 −0.β (4) 
C1—N1—C3—C2 0.1 (3) C8—C9—C10—C5 1.1 (4) 
C4—N1—C3—C2 −179.5 (γ) C6—C5—C10—C9 −1.4 (4) 
C1—N1—C4—C5 −89.γ (γ) C4—C5—C10—C9 179.3 (3) 
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Appendix A-7. Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) for compound 4 
 
 x y z Uiso*/Ueq  
I1 0.78435 (2) 0.28882 (2) 0.99037 (2) 0.02415 (5)  
N1 0.62017 (18) 0.7607 (3) 0.84311 (8) 0.0184 (3)  
C1 0.6885 (2) 0.6133 (3) 0.80429 (9) 0.0193 (4)  
H1 0.6911 0.6269 0.7557 0.023*  
N2 0.75130 (18) 0.4480 (3) 0.84125 (8) 0.0202 (3)  
C2 0.7195 (2) 0.4950 (3) 0.90773 (9) 0.0176 (4)  
C3 0.6390 (2) 0.6861 (3) 0.91019 (9) 0.0202 (4)  
H3 0.6035 0.7533 0.9497 0.024*  
C4 0.5408 (2) 0.9614 (3) 0.81736 (10) 0.0234 (4)  
H4A 0.5420 0.9692 0.7665 0.028*  
H4B 0.6011 1.0876 0.8381 0.028*  
C5 0.3709 (2) 0.9758 (3) 0.83403 (9) 0.0180 (4)  
C6 0.2651 (2) 0.8056 (3) 0.81699 (10) 0.0212 (4)  
H6 0.3005 0.6781 0.7958 0.025*  
C7 0.1081 (2) 0.8218 (3) 0.83096 (10) 0.0256 (4)  
H7 0.0365 0.7048 0.8197 0.031*  
C8 0.0554 (2) 1.0088 (4) 0.86130 (10) 0.0265 (4)  
H8 −0.05βγ 1.0201 0.8705 0.032*  
C9 0.1594 (3) 1.1779 (3) 0.87815 (11) 0.0277 (4)  
H9 0.1231 1.3058 0.8988 0.033*  
C10 0.3176 (2) 1.1619 (3) 0.86495 (10) 0.0240 (4)  
H10 0.3891 1.2783 0.8771 0.029*  
 
 
Appendix A-8. Atomic displacement parameters (Å2) for compound 4 
 
 U11 U22 U33 U12 U13 U23 
I1 0.02821 (8) 0.02566 (8) 0.01895 (7) 0.00504 (5) 0.00421 (5) 0.00451 (5) 
N1 0.0185 (8) 0.0183 (8) 0.0193 (8) 0.0004 (6) 0.0055 (6) 0.0031 (6) 
C1 0.0177 (9) 0.0255 (10) 0.0152 (8) 0.0006 (7) 0.0038 (7) −0.0016 (7) 
N2 0.0198 (8) 0.0235 (8) 0.0177 (7) 0.0025 (6) 0.0045 (6) −0.00β7 (6) 
C2 0.0171 (8) 0.0191 (9) 0.0167 (8) 0.0005 (7) 0.0027 (7) 0.0004 (7) 
C3 0.0248 (10) 0.0203 (10) 0.0167 (9) 0.0003 (7) 0.0075 (7) 0.0000 (7) 
C4 0.0248 (10) 0.0186 (9) 0.0281 (10) 0.0021 (8) 0.0089 (8) 0.0080 (8) 
C5 0.0211 (9) 0.0178 (9) 0.0151 (8) 0.0028 (7) 0.0022 (7) 0.0043 (7) 
C6 0.0259 (10) 0.0184 (9) 0.0190 (9) 0.0042 (7) 0.0009 (7) −0.00β8 (7) 
C7 0.0212 (10) 0.0305 (12) 0.0236 (10) −0.0015 (8) −0.0045 (8) −0.0048 (8) 
C8 0.0195 (9) 0.0380 (12) 0.0216 (9) 0.0078 (8) 0.0004 (7) −0.0019 (8) 
C9 0.0314 (11) 0.0263 (11) 0.0257 (10) 0.0106 (9) 0.0050 (8) −0.00γ7 (8) 
C10 0.0279 (10) 0.0185 (10) 0.0254 (10) 0.0007 (8) 0.0015 (8) −0.0010 (8) 
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Appendix A-9. Geometric parameters (Å, º) for compound 4 
 
I1—C2 2.0717 (18) C5—C10 1.391 (3) 
N1—C1 1.349 (2) C5—C6 1.393 (3) 
N1—C3 1.374 (2) C6—C7 1.388 (3) 
N1—C4 1.467 (2) C6—H6 0.9500 
C1—N2 1.322 (2) C7—C8 1.388 (3) 
C1—H1 0.9500 C7—H7 0.9500 
N2—C2 1.379 (2) C8—C9 1.378 (3) 
C2—C3 1.362 (3) C8—H8 0.9500 
C3—H3 0.9500 C9—C10 1.394 (3) 
C4—C5 1.510 (3) C9—H9 0.9500 
C4—H4A 0.9900 C10—H10 0.9500 
C4—H4B 0.9900   
C1—N1—C3 107.09 (15) C10—C5—C6 119.40 (17) 
C1—N1—C4 125.67 (16) C10—C5—C4 120.18 (18) 
C3—N1—C4 127.24 (16) C6—C5—C4 120.39 (17) 
N2—C1—N1 112.62 (16) C7—C6—C5 120.18 (18) 
N2—C1—H1 123.7 C7—C6—H6 119.9 
N1—C1—H1 123.7 C5—C6—H6 119.9 
C1—N2—C2 103.82 (15) C8—C7—C6 120.08 (19) 
C3—C2—N2 111.35 (16) C8—C7—H7 120.0 
C3—C2—I1 126.28 (13) C6—C7—H7 120.0 
N2—C2—I1 122.34 (13) C9—C8—C7 120.02 (19) 
C2—C3—N1 105.11 (16) C9—C8—H8 120.0 
C2—C3—H3 127.4 C7—C8—H8 120.0 
N1—C3—H3 127.4 C8—C9—C10 120.24 (19) 
N1—C4—C5 112.76 (15) C8—C9—H9 119.9 
N1—C4—H4A 109.0 C10—C9—H9 119.9 
C5—C4—H4A 109.0 C5—C10—C9 120.08 (19) 
N1—C4—H4B 109.0 C5—C10—H10 120.0 
C5—C4—H4B 109.0 C9—C10—H10 120.0 
H4A—C4—H4B 107.8   
C3—N1—C1—N2 −0.γ (β) N1—C4—C5—C10 129.69 (19) 
C4—N1—C1—N2 179.94 (17) N1—C4—C5—C6 −5β.0 (β) 
N1—C1—N2—C2 0.3 (2) C10—C5—C6—C7 −0.β (γ) 
C1—N2—C2—C3 −0.1 (β) C4—C5—C6—C7 −178.49 (18) 
C1—N2—C2—I1 178.38 (13) C5—C6—C7—C8 0.7 (3) 
N2—C2—C3—N1 0.0 (2) C6—C7—C8—C9 −0.6 (γ) 
I1—C2—C3—N1 −178.47 (1γ) C7—C8—C9—C10 −0.1 (γ) 
C1—N1—C3—C2 0.2 (2) C6—C5—C10—C9 −0.5 (γ) 
C4—N1—C3—C2 179.96 (17) C4—C5—C10—C9 177.82 (18) 
C1—N1—C4—C5 123.20 (19) C8—C9—C10—C5 0.7 (3) 
C3—N1—C4—C5 −56.5 (γ)   
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Appendix A-10. Hydrogen-bond geometry (Å, º) for compound 4 
 
Donor—H···Acceptor Donor-H H···Acceptor Donor···Acceptor Angle 
C4—H4B···N2 0.99 2.55 3.488 (3) 158 
C4—H4B···N2 0.99 2.55 3.488 (3) 158 
C4—H4B···N2 0.99 2.55 3.488 (3) 158 
C4—H4B···N2 0.99 2.55 3.488 (3) 158 
 
 
Appendix A-11. Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) for compound 5 
 
 x y z Uiso*/Ueq  
I1 0.36505 (2) 0.21176 (2) −0.00445 (β) 0.01647 (5)  
N1 0.6779 (2) 0.27787 (17) 0.20512 (12) 0.0120 (3)  
C1 0.4707 (3) 0.2345 (2) 0.16333 (14) 0.0128 (3)  
N2 0.3471 (2) 0.20232 (18) 0.23569 (12) 0.0150 (3)  
C2 0.4817 (3) 0.2263 (2) 0.33480 (14) 0.0139 (3)  
C3 0.4394 (3) 0.2054 (2) 0.43956 (15) 0.0182 (3)  
H3 0.3012 0.1724 0.4531 0.022*  
C4 0.6071 (3) 0.2349 (2) 0.52297 (15) 0.0194 (4)  
H4 0.5828 0.2201 0.5945 0.023*  
C5 0.8118 (3) 0.2859 (2) 0.50456 (15) 0.0175 (3)  
H5 0.9221 0.3057 0.5641 0.021*  
C6 0.8566 (3) 0.3081 (2) 0.40127 (15) 0.0151 (3)  
H6 0.9943 0.3438 0.3885 0.018*  
C7 0.6875 (3) 0.2749 (2) 0.31748 (14) 0.0122 (3)  
C8 0.8525 (3) 0.3389 (2) 0.15353 (14) 0.0132 (3)  
H8B 0.8223 0.2938 0.0691 0.016*  
H8A 0.9799 0.2929 0.1749 0.016*  
C9 0.8940 (3) 0.5343 (2) 0.19092 (13) 0.0117 (3)  
C10 1.0811 (3) 0.6095 (2) 0.16685 (15) 0.0158 (3)  
H10 1.1789 0.5383 0.1290 0.019*  
C11 1.1250 (3) 0.7877 (2) 0.19790 (15) 0.0177 (3)  
H11 1.2523 0.8376 0.1811 0.021*  
C12 0.9832 (3) 0.8928 (2) 0.25341 (15) 0.0160 (3)  
H12 1.0129 1.0144 0.2742 0.019*  
C13 0.7972 (3) 0.8192 (2) 0.27853 (14) 0.0150 (3)  
H13 0.7006 0.8907 0.3173 0.018*  
C14 0.7526 (3) 0.6401 (2) 0.24673 (14) 0.0136 (3)  
H14 0.6250 0.5904 0.2633 0.016*  
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Appendix A-12. Atomic displacement parameters (Å2) for compound 5 
 
 U11 U22 U33 U12 U13 U23 
I1 0.01853 (7) 
0.01995 
(7) 
0.01172 
(6) 
0.00853 
(4) 
0.00073 
(4) 
0.00460 
(4) 
N1 0.0124 (6) 0.0118 (6) 0.0118 (6) 0.0009 (5) 0.0018 (5) 0.0038 (5) 
C1 0.0145 (8) 0.0118 (7) 0.0120 (7) 0.0031 (6) 0.0003 (6) 0.0036 (6) 
N2 0.0129 (7) 0.0168 (7) 0.0161 (7) 0.0012 (5) 0.0005 (5) 0.0069 (6) 
C2 0.0138 (8) 0.0130 (7) 0.0157 (8) 0.0018 (6) 0.0016 (6) 0.0058 (6) 
C3 0.0155 (8) 0.0236 (9) 0.0182 (8) 0.0018 (7) 0.0050 (7) 0.0099 (7) 
C4 0.0229 (9) 0.0238 (9) 0.0144 (8) 0.0035 (7) 0.0036 (7) 0.0098 (7) 
C5 0.0193 (9) 0.0179 (8) 0.0144 (8) 0.0025 (7) −0.00β6 (7) 0.0048 (6) 
C6 0.0133 (8) 0.0136 (7) 0.0170 (8) 0.0005 (6) 0.0001 (6) 0.0038 (6) 
C7 0.0158 (8) 0.0099 (7) 0.0113 (7) 0.0021 (6) 0.0025 (6) 0.0035 (6) 
C8 0.0121 (7) 0.0135 (7) 0.0148 (8) 0.0016 (6) 0.0046 (6) 0.0049 (6) 
C9 0.0130 (7) 0.0128 (7) 0.0102 (7) 0.0022 (6) 0.0003 (6) 0.0051 (6) 
C10 0.0142 (8) 0.0165 (8) 0.0174 (8) 0.0040 (6) 0.0051 (6) 0.0049 (6) 
C11 0.0155 (8) 0.0190 (8) 0.0194 (8) −0.0008 (6) 0.0040 (7) 0.0078 (7) 
C12 0.0199 (8) 0.0129 (7) 0.0151 (8) 0.0010 (6) 0.0011 (6) 0.0048 (6) 
C13 0.0161 (8) 0.0142 (8) 0.0150 (8) 0.0045 (6) 0.0028 (6) 0.0043 (6) 
C14 0.0122 (7) 0.0159 (8) 0.0141 (8) 0.0021 (6) 0.0029 (6) 0.0063 (6) 
 
 
Appendix A-13. Geometric parameters (Å, º) for compound 5 
 
I1—C1 2.0787 (16) C6—H6 0.9500 
N1—C1 1.372 (2) C8—C9 1.522 (2) 
N1—C7 1.392 (2) C8—H8B 0.9900 
N1—C8 1.459 (2) C8—H8A 0.9900 
C1—N2 1.310 (2) C9—C14 1.392 (2) 
N2—C2 1.398 (2) C9—C10 1.399 (2) 
C2—C3 1.399 (2) C10—C11 1.392 (2) 
C2—C7 1.403 (2) C10—H10 0.9500 
C3—C4 1.388 (3) C11—C12 1.389 (2) 
C3—H3 0.9500 C11—H11 0.9500 
C4—C5 1.406 (3) C12—C13 1.394 (2) 
C4—H4 0.9500 C12—H12 0.9500 
C5—C6 1.390 (2) C13—C14 1.399 (2) 
C5—H5 0.9500 C13—H13 0.9500 
C6—C7 1.393 (2) C14—H14 0.9500 
C1—N1—C7 105.30 (13) N1—C8—C9 112.67 (13) 
C1—N1—C8 129.42 (14) N1—C8—H8B 109.1 
C7—N1—C8 124.77 (14) C9—C8—H8B 109.1 
N2—C1—N1 114.90 (14) N1—C8—H8A 109.1 
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Appendix A-13, cont. 
 
N2—C1—I1 122.95 (12) C9—C8—H8A 109.1 
N1—C1—I1 122.10 (12) H8B—C8—H8A 107.8 
C1—N2—C2 103.99 (14) C14—C9—C10 119.12 (15) 
N2—C2—C3 130.02 (16) C14—C9—C8 122.54 (14) 
N2—C2—C7 110.06 (14) C10—C9—C8 118.33 (14) 
C3—C2—C7 119.90 (16) C11—C10—C9 120.50 (16) 
C4—C3—C2 117.39 (16) C11—C10—H10 119.8 
C4—C3—H3 121.3 C9—C10—H10 119.8 
C2—C3—H3 121.3 C12—C11—C10 120.19 (16) 
C3—C4—C5 121.86 (16) C12—C11—H11 119.9 
C3—C4—H4 119.1 C10—C11—H11 119.9 
C5—C4—H4 119.1 C11—C12—C13 119.71 (15) 
C6—C5—C4 121.53 (16) C11—C12—H12 120.1 
C6—C5—H5 119.2 C13—C12—H12 120.1 
C4—C5—H5 119.2 C12—C13—C14 120.09 (16) 
C5—C6—C7 116.04 (16) C12—C13—H13 120.0 
C5—C6—H6 122.0 C14—C13—H13 120.0 
C7—C6—H6 122.0 C9—C14—C13 120.39 (15) 
N1—C7—C6 131.00 (15) C9—C14—H14 119.8 
N1—C7—C2 105.74 (14) C13—C14—H14 119.8 
C6—C7—C2 123.26 (15)   
C7—N1—C1—N2 −0.68 (19) C5—C6—C7—C2 1.7 (2) 
C8—N1—C1—N2 −17β.65 (15) N2—C2—C7—N1 −0.90 (18) 
C7—N1—C1—I1 −178.β0 (11) C3—C2—C7—N1 177.77 (15) 
C8—N1—C1—I1 9.8 (2) N2—C2—C7—C6 179.92 (15) 
N1—C1—N2—C2 0.12 (19) C3—C2—C7—C6 −1.4 (γ) 
I1—C1—N2—C2 177.62 (11) C1—N1—C8—C9 93.38 (19) 
C1—N2—C2—C3 −178.00 (18) C7—N1—C8—C9 −77.17 (19) 
C1—N2—C2—C7 0.49 (18) N1—C8—C9—C14 −1γ.4 (β) 
N2—C2—C3—C4 178.48 (17) N1—C8—C9—C10 167.25 (14) 
C7—C2—C3—C4 0.1 (3) C14—C9—C10—C11 −0.β (β) 
C2—C3—C4—C5 0.8 (3) C8—C9—C10—C11 179.10 (15) 
C3—C4—C5—C6 −0.5 (γ) C9—C10—C11—C12 0.1 (3) 
C4—C5—C6—C7 −0.7 (3) C10—C11—C12—C13 0.4 (3) 
C1—N1—C7—C6 −179.98 (17) C11—C12—C13—C14 −0.8 (γ) 
C8—N1—C7—C6 −7.5 (γ) C10—C9—C14—C13 −0.1 (β) 
C1—N1—C7—C2 0.92 (17) C8—C9—C14—C13 −179.45 (15) 
C8—N1—C7—C2 173.37 (14) C12—C13—C14—C9 0.6 (3) 
C5—C6—C7—N1 −177.β9 (16)    
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Appendix A-14. Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) for compound 13 
 
 x y z Uiso*/Ueq 
     
O1 0.2589 (3) 0.3212 (2) 0.57357 (15) 0.0311 (5) 
N1 0.2368 (4) 0.4800 (3) −0.00β7β (19) 0.0288 (6) 
C1 0.2531 (4) 0.4554 (3) −0.106β (β) 0.0313 (7) 
H1 0.2271 0.5334 −0.1γβ1 0.038* 
O2 0.2716 (3) 0.6019 (2) 0.68566 (14) 0.0305 (5) 
N2 0.1769 (4) 0.7836 (3) 0.11557 (19) 0.0289 (6) 
H2N 0.180 (5) 0.6857 (12) 0.084 (2) 0.035* 
C2 0.3049 (5) 0.3244 (4) −0.1777 (2) 0.0334 (7) 
H2 0.3145 0.3129 −0.β506 0.040* 
N3 0.1808 (4) 1.0086 (3) 0.24033 (19) 0.0338 (6) 
C3 0.3424 (4) 0.2110 (3) −0.141β (β) 0.0329 (7) 
H3 0.3781 0.1192 −0.1886 0.039* 
C4 0.3277 (4) 0.2320 (3) −0.0γγ7 (β) 0.0299 (7) 
H4 0.3534 0.1549 −0.0068 0.036* 
C5 0.2748 (4) 0.3675 (3) 0.0333 (2) 0.0282 (7) 
C6 0.2560 (4) 0.3968 (3) 0.1450 (2) 0.0282 (7) 
C7 0.2432 (4) 0.4237 (3) 0.2385 (2) 0.0282 (7) 
C8 0.2401 (4) 0.4691 (3) 0.3528 (2) 0.0263 (7) 
C9 0.2468 (4) 0.3660 (3) 0.4053 (2) 0.0275 (7) 
H9 0.2467 0.2633 0.3646 0.033* 
C10 0.2536 (4) 0.4134 (3) 0.5166 (2) 0.0269 (7) 
C11 0.2575 (4) 0.5652 (3) 0.5766 (2) 0.0276 (7) 
C12 0.2451 (4) 0.6673 (3) 0.5254 (2) 0.0265 (6) 
H12 0.2417 0.7695 0.5665 0.032* 
C13 0.2375 (4) 0.6206 (3) 0.4130 (2) 0.0260 (6) 
C14 0.2227 (4) 0.7229 (3) 0.3575 (2) 0.0293 (7) 
C15 0.2086 (5) 0.7954 (3) 0.3007 (2) 0.0303 (7) 
C16 0.1876 (4) 0.8645 (3) 0.2224 (2) 0.0290 (7) 
C17 0.1612 (5) 0.8807 (3) 0.0632 (2) 0.0319 (7) 
H17 0.1506 0.8575 −0.01βγ 0.038* 
C18 0.1636 (5) 1.0164 (3) 0.1386 (2) 0.0344 (7) 
H18 0.1546 1.1055 0.1241 0.041* 
C19 0.2497 (5) 0.1666 (3) 0.5147 (2) 0.0356 (8) 
H19A 0.1282 0.1367 0.4630 0.053* 
H19B 0.2459 0.1122 0.5642 0.053* 
H19C 0.3687 0.1443 0.4763 0.053* 
C20 0.2961 (5) 0.7562 (3) 0.7483 (2) 0.0352 (8) 
H20A 0.4098 0.8032 0.7273 0.053* 
H20B 0.3219 0.7695 0.8245 0.053* 
H20C 0.1732 0.8020 0.7363 0.053* 
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Appendix A-15. Atomic displacement parameters (Å2) for compound 13 
 
 U11 U22 U33 U12 U13 U23 
O1 0.0398 (12) 0.0368 (13) 0.0222 (11) 0.0042 (9) 0.0041 (9) 0.0169 (9) 
N1 0.0287 (14) 0.0386 (15) 0.0223 (13) 0.0015 (11) 0.0031 (10) 0.0150 (11) 
C1 0.0338 (17) 0.0390 (18) 0.0254 (16) 0.0009 (13) −0.0010 (1γ) 0.0182 (14) 
O2 0.0386 (12) 0.0415 (13) 0.0139 (10) 0.0049 (9) 0.0036 (8) 0.0126 (9) 
N2 0.0334 (14) 0.0337 (14) 0.0213 (13) 0.0055 (11) 0.0041 (10) 0.0113 (11) 
C2 0.0358 (17) 0.049 (2) 0.0186 (15) 0.0000 (14) 0.0008 (13) 0.0162 (14) 
N3 0.0461 (16) 0.0340 (15) 0.0245 (13) 0.0027 (12) 0.0029 (11) 0.0147 (11) 
C3 0.0356 (18) 0.0367 (18) 0.0245 (16) 0.0032 (13) 0.0062 (13) 0.0079 (13) 
C4 0.0320 (16) 0.0369 (18) 0.0242 (16) −0.000γ (1γ) 0.0027 (12) 0.0159 (13) 
C5 0.0294 (16) 0.0372 (18) 0.0208 (15) 0.0017 (13) 0.0028 (12) 0.0140 (13) 
C6 0.0330 (17) 0.0298 (16) 0.0248 (16) 0.0031 (12) 0.0032 (12) 0.0137 (13) 
C7 0.0322 (16) 0.0327 (17) 0.0232 (16) 0.0050 (13) 0.0049 (12) 0.0134 (13) 
C8 0.0246 (15) 0.0385 (18) 0.0193 (15) 0.0042 (12) 0.0049 (11) 0.0138 (13) 
C9 0.0266 (16) 0.0381 (18) 0.0204 (15) 0.0043 (12) 0.0024 (12) 0.0136 (13) 
C10 0.0249 (15) 0.0383 (18) 0.0224 (15) 0.0037 (12) 0.0036 (11) 0.0164 (13) 
C11 0.0287 (16) 0.0408 (18) 0.0157 (14) 0.0028 (13) 0.0037 (11) 0.0127 (13) 
C12 0.0264 (15) 0.0352 (17) 0.0205 (15) 0.0047 (12) 0.0035 (12) 0.0126 (13) 
C13 0.0243 (15) 0.0354 (17) 0.0222 (15) 0.0051 (12) 0.0036 (11) 0.0146 (13) 
C14 0.0303 (16) 0.0360 (17) 0.0214 (15) 0.0024 (13) 0.0039 (12) 0.0097 (13) 
C15 0.0358 (17) 0.0353 (17) 0.0212 (15) 0.0047 (13) 0.0004 (12) 0.0121 (13) 
C16 0.0280 (16) 0.0404 (18) 0.0212 (15) 0.0020 (13) 0.0028 (12) 0.0142 (13) 
C17 0.0388 (18) 0.0356 (18) 0.0262 (16) 0.0047 (14) 0.0039 (13) 0.0171 (14) 
C18 0.0435 (19) 0.0376 (18) 0.0293 (17) 0.0018 (14) 0.0008 (14) 0.0216 (14) 
C19 0.047 (2) 0.0377 (19) 0.0287 (17) 0.0044 (15) 0.0056 (14) 0.0191 (14) 
C20 0.0452 (19) 0.0411 (19) 0.0199 (15) 0.0069 (15) 0.0057 (13) 0.0107 (13) 
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Appendix A-16. Geometric parameters (Å, °) for compound 13 
 
O1—C10 1.359 (3) C7—C8 1.438 (4) 
O1—C19 1.420 (3) C8—C9 1.405 (4) 
N1—C1 1.336 (4) C8—C13 1.405 (4) 
N1—C5 1.360 (4) C9—C10 1.393 (4) 
C1—C2 1.377 (4) C9—H9 0.9500 
C1—H1 0.9500 C10—C11 1.402 (4) 
O2—C11 1.370 (3) C11—C12 1.384 (4) 
O2—C20 1.425 (3) C12—C13 1.407 (4) 
N2—C17 1.356 (4) C12—H12 0.9500 
N2—C16 1.362 (4) C13—C14 1.430 (4) 
N2—H2N 0.892 (10) C14—C15 1.200 (4) 
C2—C3 1.371 (4) C15—C16 1.426 (4) 
C2—H2 0.9500 C17—C18 1.346 (4) 
N3—C16 1.331 (4) C17—H17 0.9500 
N3—C18 1.383 (4) C18—H18 0.9500 
C3—C4 1.394 (4) C19—H19A 0.9800 
C3—H3 0.9500 C19—H19B 0.9800 
C4—C5 1.388 (4) C19—H19C 0.9800 
C4—H4 0.9500 C20—H20A 0.9800 
C5—C6 1.439 (4) C20—H20B 0.9800 
C6—C7 1.199 (4) C20—H20C 0.9800 
C10—O1—C19 117.3 (2) O2—C11—C12 124.0 (3) 
C1—N1—C5 117.2 (2) O2—C11—C10 115.6 (2) 
N1—C1—C2 124.3 (3) C12—C11—C10 120.4 (3) 
N1—C1—H1 117.8 C11—C12—C13 120.4 (3) 
C2—C1—H1 117.8 C11—C12—H12 119.8 
C11—O2—C20 116.4 (2) C13—C12—H12 119.8 
C17—N2—C16 106.8 (3) C8—C13—C12 119.5 (3) 
C17—N2—H2N 125 (2) C8—C13—C14 118.7 (2) 
C16—N2—H2N 128 (2) C12—C13—C14 121.8 (3) 
C3—C2—C1 118.3 (3) C15—C14—C13 172.8 (3) 
C3—C2—H2 120.8 C14—C15—C16 172.9 (3) 
C1—C2—H2 120.8 N3—C16—N2 111.7 (3) 
C16—N3—C18 103.9 (2) N3—C16—C15 127.1 (3) 
C2—C3—C4 119.3 (3) N2—C16—C15 121.2 (3) 
C2—C3—H3 120.4 C18—C17—N2 106.8 (3) 
C4—C3—H3 120.4 C18—C17—H17 126.6 
C5—C4—C3 118.9 (3) N2—C17—H17 126.6 
C5—C4—H4 120.6 C17—C18—N3 110.8 (3) 
C3—C4—H4 120.6 C17—C18—H18 124.6 
N1—C5—C4 122.0 (3) N3—C18—H18 124.6 
N1—C5—C6 116.0 (2) O1—C19—H19A 109.5 
C4—C5—C6 121.9 (3) O1—C19—H19B 109.5 
C7—C6—C5 178.7 (3) H19A—C19—H19B 109.5 
C6—C7—C8 174.4 (3) O1—C19—H19C 109.5 
C9—C8—C13 119.7 (3) H19A—C19—H19C 109.5 
C9—C8—C7 121.4 (3) H19B—C19—H19C 109.5 
C13—C8—C7 118.9 (2) O2—C20—H20A 109.5 
C10—C9—C8 120.3 (3) O2—C20—H20B 109.5 
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C10—C9—H9 119.8 H20A—C20—H20B 109.5 
C8—C9—H9 119.8 O2—C20—H20C 109.5 
O1—C10—C9 124.1 (3) H20A—C20—H20C 109.5 
O1—C10—C11 116.1 (2) H20B—C20—H20C 109.5 
C9—C10—C11 119.7 (3)   
C5—N1—C1—C2 0.2 (4) O1—C10—C11—C12 −177.6 (γ) 
N1—C1—C2—C3 0.1 (5) C9—C10—C11—C12 3.1 (4) 
C1—C2—C3—C4 −0.β (4) O2—C11—C12—C13 178.0 (2) 
C2—C3—C4—C5 0.1 (4) C10—C11—C12—C13 −β.9 (4) 
C1—N1—C5—C4 −0.β (4) C9—C8—C13—C12 1.0 (4) 
C1—N1—C5—C6 −179.9 (β) C7—C8—C13—C12 −176.7 (γ) 
C3—C4—C5—N1 0.1 (4) C9—C8—C13—C14 −177.6 (γ) 
C3—C4—C5—C6 179.8 (3) C7—C8—C13—C14 4.7 (4) 
C13—C8—C9—C10 −0.8 (4) C11—C12—C13—C8 0.8 (4) 
C7—C8—C9—C10 176.8 (3) C11—C12—C13—C14 179.4 (3) 
C19—O1—C10—C9 −β.γ (4) C18—N3—C16—N2 0.4 (3) 
C19—O1—C10—C11 178.4 (2) C18—N3—C16—C15 178.8 (3) 
C8—C9—C10—O1 179.5 (2) C17—N2—C16—N3 −0.5 (γ) 
C8—C9—C10—C11 −1.β (4) C17—N2—C16—C15 −178.9 (γ) 
C20—O2—C11—C12 −6.8 (4) C16—N2—C17—C18 0.3 (3) 
C20—O2—C11—C10 173.9 (2) N2—C17—C18—N3 0.0 (3) 
O1—C10—C11—O2 1.7 (4) C16—N3—C18—C17 −0.γ (γ) 
C9—C10—C11—O2 −177.7 (β)   
 
 
Appendix A-17. Hydrogen-bond geometry (Å, °) for compound 13 
 
D—H···A Donor—H H···Acceptor Donor···Acceptor Angle 
C2—H2···O1 0.95 2.38 3.303 (4) 164 
C9—H9···N3 0.95 2.43 3.369 (4) 168 
N2—H2N···N1 0.89 (1) 2.00 (1) 2.874 (4) 167 (3) 
C2—H2···O1 0.95 2.38 3.303 (4) 164 
N2—H2N···N1 0.89 (1) 2.00 (1) 2.874 (4) 167 (3) 
C2—H2···O1 0.95 2.38 3.303 (4) 164 
C9—H9···N3 0.95 2.43 3.369 (4) 168 
C2—H2···O1 0.95 2.38 3.303 (4) 164 
C9—H9···N3 0.95 2.43 3.369 (4) 168 
C9—H9···N3 0.95 2.43 3.369 (4) 168 
N2—H2N···N1 0.89 (1) 2.00 (1) 2.874 (4) 167 (3) 
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Appendix A-18. Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) for compound 13.PdCl2 
 
 x y z Uiso*/Ueq 
Pd1 1.07271 (2) 0.12824 (2) 0.77120 (4) 0.01568 (9) 
Cl1 1.22830 (8) 0.11273 (3) 0.59441 (13) 0.0248 (2) 
O1 0.4002 (2) 0.15228 (10) 0.1247 (4) 0.0245 (6) 
N1 1.0259 (3) 0.05703 (10) 0.7525 (4) 0.0168 (6) 
C1 1.1005 (3) 0.02246 (14) 0.8281 (5) 0.0219 (8) 
H1 1.1753 0.0323 0.8903 0.026* 
Cl2 0.92913 (9) 0.14172 (3) 0.97352 (12) 0.0240 (2) 
O2 0.4587 (2) 0.24354 (9) 0.1387 (4) 0.0229 (6) 
N2 1.1124 (3) 0.19978 (10) 0.7785 (4) 0.0155 (6) 
C2 1.0730 (4) −0.0β644 (14) 0.8193 (5) 0.0242 (8) 
H2 1.1286 −0.0499 0.8725 0.029* 
N3 1.0819 (3) 0.27840 (11) 0.7249 (4) 0.0201 (6) 
H3N 1.044 (4) 0.3051 (17) 0.688 (6) 0.024* 
C3 0.9644 (4) −0.04087 (14) 0.7330 (5) 0.0239 (8) 
H3 0.9426 −0.0745 0.7286 0.029* 
C4 0.8879 (3) −0.0065γ (1γ) 0.6531 (5) 0.0216 (8) 
H4 0.8130 −0.016β 0.5907 0.026* 
C5 0.9191 (3) 0.04264 (13) 0.6629 (5) 0.0183 (7) 
C6 0.8428 (3) 0.07952 (14) 0.5712 (5) 0.0221 (8) 
C7 0.7765 (3) 0.10708 (13) 0.4845 (5) 0.0197 (7) 
C8 0.6988 (3) 0.14240 (14) 0.3920 (5) 0.0207 (7) 
C9 0.5875 (3) 0.12801 (14) 0.2987 (5) 0.0211 (7) 
H9 0.5657 0.0944 0.2937 0.025* 
C10 0.5099 (3) 0.16253 (14) 0.2143 (5) 0.0212 (7) 
C11 0.5423 (3) 0.21242 (14) 0.2216 (5) 0.0201 (7) 
C12 0.6514 (3) 0.22678 (14) 0.3100 (5) 0.0205 (7) 
H12 0.6734 0.2603 0.3125 0.025* 
C13 0.7299 (3) 0.19195 (14) 0.3965 (5) 0.0201 (7) 
C14 0.8387 (3) 0.20787 (13) 0.4989 (5) 0.0207 (7) 
C15 0.9284 (3) 0.22085 (13) 0.5898 (5) 0.0199 (7) 
C16 1.0367 (3) 0.23264 (13) 0.6953 (5) 0.0172 (7) 
C17 1.2094 (3) 0.22510 (13) 0.8628 (5) 0.0188 (7) 
H17 1.2773 0.2110 0.9317 0.023* 
C18 1.1912 (3) 0.27419 (14) 0.8301 (5) 0.0249 (8) 
H18 1.2436 0.3001 0.8716 0.030* 
C19 0.3534 (4) 0.10390 (15) 0.1406 (6) 0.0307 (9) 
H19A 0.4050 0.0806 0.0845 0.046* 
H19B 0.2713 0.1023 0.0793 0.046* 
H19C 0.3520 0.0957 0.2688 0.046* 
C20 0.4758 (3) 0.29462 (13) 0.1773 (5) 0.0225 (8) 
H20A 0.4834 0.2997 0.3086 0.034* 
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Appendix A-19. Atomic displacement parameters (Å2) for compound 13.PdCl2 
 
 U11 U22 U33 U12 U13 U23 
Pd1 0.01706 (14) 0.01209 
(14) 
0.01776 
(14) 
0.00119 (10) 0.00103 (10) 0.00135 (10) 
Cl1 0.0264 (5) 0.0169 (4) 0.0333 (5) −0.00γ6 (γ) 0.0126 (4) −0.00γ1 (4) 
O1 0.0202 (13) 0.0233 (14) 0.0282 (15) −0.0014 (10) −0.0065 (11) 0.0019 (11) 
N1 0.0203 (14) 0.0135 (13) 0.0167 (14) 0.0012 (11) 0.0019 (11) 0.0003 (11) 
C1 0.0227 (18) 0.0255 (19) 0.0178 (17) 0.0034 (15) 0.0029 (14) 0.0024 (15) 
Cl2 0.0384 (5) 0.0126 (4) 0.0225 (4) −0.00γ7 (γ) 0.0098 (4) 0.0003 (3) 
O2 0.0194 (13) 0.0225 (13) 0.0256 (14) 0.0027 (10) −0.00γ1 (11) 0.0041 (11) 
N2 0.0169 (14) 0.0141 (14) 0.0152 (14) 0.0006 (11) 0.0009 (11) 0.0004 (11) 
C2 0.034 (2) 0.0172 (18) 0.0222 (19) 0.0045 (15) 0.0084 (16) 0.0035 (14) 
N3 0.0261 (16) 0.0145 (15) 0.0203 (16) 0.0003 (12) 0.0048 (13) 0.0014 (12) 
C3 0.032 (2) 0.0204 (18) 0.0204 (18) 0.0014 (15) 0.0074 (16) 0.0004 (14) 
C4 0.0257 (19) 0.0204 (18) 0.0195 (18) −0.0059 (15) 0.0056 (15) −0.00ββ (14) 
C5 0.0193 (17) 0.0208 (18) 0.0156 (16) 0.0032 (14) 0.0050 (13) 0.0018 (14) 
C6 0.0183 (17) 0.0230 (19) 0.0253 (19) 0.0008 (14) 0.0038 (15) −0.0006 (15) 
C7 0.0199 (17) 0.0179 (17) 0.0215 (18) −0.0001 (14) 0.0031 (14) 0.0000 (14) 
C8 0.0184 (17) 0.0290 (19) 0.0147 (17) 0.0060 (15) 0.0011 (13) 0.0010 (14) 
C9 0.0211 (18) 0.0214 (18) 0.0208 (18) 0.0018 (14) 0.0016 (14) −0.0019 (14) 
C10 0.0177 (17) 0.0285 (19) 0.0171 (17) 0.0009 (14) 0.0006 (14) −0.0016 (14) 
C11 0.0176 (17) 0.0262 (19) 0.0166 (17) 0.0034 (14) 0.0020 (13) 0.0032 (14) 
C12 0.0174 (17) 0.0239 (19) 0.0208 (18) 0.0025 (14) 0.0039 (14) 0.0046 (14) 
C13 0.0152 (17) 0.0256 (19) 0.0193 (18) 0.0027 (14) 0.0014 (14) 0.0019 (14) 
C14 0.0199 (18) 0.0202 (18) 0.0224 (18) 0.0049 (14) 0.0041 (15) 0.0036 (14) 
C15 0.0196 (18) 0.0218 (18) 0.0189 (18) 0.0035 (14) 0.0047 (14) 0.0012 (14) 
C16 0.0174 (17) 0.0161 (16) 0.0181 (17) 0.0012 (13) 0.0022 (14) −0.0007 (1γ) 
C17 0.0156 (17) 0.0243 (18) 0.0164 (17) −0.0014 (14) 0.0009 (13) −0.0004 (14) 
C18 0.0250 (19) 0.026 (2) 0.025 (2) −0.0101 (15) 0.0060 (16) −0.0067 (15) 
C20 0.0226 (19) 0.0214 (18) 0.0236 (19) 0.0036 (14) 0.0026 (15) 0.0049 (15) 
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Appendix A-20. Geometric parameters (Å, °) for compound 13.PdCl2 
 
Pd1—N2 2.006 (3) C5—C6 1.444 (5) 
Pd1—N1 2.018 (3) C6—C7 1.197 (5) 
Pd1—Cl1 2.3185 (9) C7—C8 1.426 (5) 
Pd1—Cl2 2.3336 (10) C8—C13 1.399 (5) 
O1—C10 1.360 (4) C8—C9 1.413 (5) 
O1—C19 1.432 (5) C9—C10 1.386 (5) 
N1—C1 1.343 (5) C9—H9 0.9500 
N1—C5 1.361 (5) C10—C11 1.411 (5) 
C1—C2 1.373 (5) C11—C12 1.378 (5) 
C1—H1 0.9500 C12—C13 1.404 (5) 
O2—C11 1.362 (4) C12—H12 0.9500 
O2—C20 1.436 (4) C13—C14 1.431 (5) 
N2—C16 1.340 (4) C14—C15 1.201 (5) 
N2—C17 1.379 (4) C15—C16 1.407 (5) 
C2—C3 1.368 (6) C17—C18 1.376 (5) 
C2—H2 0.9500 C17—H17 0.9500 
N3—C16 1.359 (5) C18—H18 0.9500 
N3—C18 1.383 (5) C19—H19A 0.9800 
N3—H3N 0.87 (5) C19—H19B 0.9800 
C3—C4 1.363 (5) C19—H19C 0.9800 
C3—H3 0.9500 C20—H20A 0.9800 
C4—C5 1.390 (5) C20—H20B 0.9800 
C4—H4 0.9500 C20—H20C 0.9800 
N2—Pd1—N1 176.87 (12) C10—C9—H9 119.8 
N2—Pd1—Cl1 91.05 (9) C8—C9—H9 119.8 
N1—Pd1—Cl1 89.27 (9) O1—C10—C9 124.6 (3) 
N2—Pd1—Cl2 89.56 (9) O1—C10—C11 115.6 (3) 
N1—Pd1—Cl2 90.42 (9) C9—C10—C11 119.8 (3) 
Cl1—Pd1—Cl2 174.40 (4) O2—C11—C12 124.5 (3) 
C10—O1—C19 117.8 (3) O2—C11—C10 115.3 (3) 
C1—N1—C5 118.2 (3) C12—C11—C10 120.2 (3) 
C1—N1—Pd1 120.4 (3) C11—C12—C13 120.2 (3) 
C5—N1—Pd1 121.3 (2) C11—C12—H12 119.9 
N1—C1—C2 122.8 (4) C13—C12—H12 119.9 
N1—C1—H1 118.6 C8—C13—C12 120.3 (3) 
C2—C1—H1 118.6 C8—C13—C14 120.1 (3) 
C11—O2—C20 116.6 (3) C12—C13—C14 119.4 (3) 
C16—N2—C17 107.4 (3) C15—C14—C13 177.9 (4) 
C16—N2—Pd1 121.1 (2) C14—C15—C16 175.9 (4) 
C17—N2—Pd1 131.5 (2) N2—C16—N3 109.8 (3) 
C3—C2—C1 119.1 (4) N2—C16—C15 124.5 (3) 
C3—C2—H2 120.5 N3—C16—C15 125.7 (3) 
C1—C2—H2 120.5 C18—C17—N2 108.4 (3) 
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Appendix A-20, cont. 
 
C16—N3—C18 107.8 (3) C18—C17—H17 125.8 
C16—N3—H3N 124 (3) N2—C17—H17 125.8 
C18—N3—H3N 128 (3) C17—C18—N3 106.6 (3) 
C4—C3—C2 119.3 (4) C17—C18—H18 126.7 
C4—C3—H3 120.4 N3—C18—H18 126.7 
C2—C3—H3 120.4 O1—C19—H19A 109.5 
C3—C4—C5 120.2 (4) O1—C19—H19B 109.5 
C3—C4—H4 119.9 H19A—C19—H19B 109.5 
C5—C4—H4 119.9 O1—C19—H19C 109.5 
N1—C5—C4 120.5 (3) H19A—C19—H19C 109.5 
N1—C5—C6 118.1 (3) H19B—C19—H19C 109.5 
C4—C5—C6 121.3 (3) O2—C20—H20A 109.5 
C7—C6—C5 174.4 (4) O2—C20—H20B 109.5 
C6—C7—C8 175.7 (4) H20A—C20—H20B 109.5 
C13—C8—C9 119.0 (3) O2—C20—H20C 109.5 
C13—C8—C7 120.5 (3) H20A—C20—H20C 109.5 
C9—C8—C7 120.4 (3) H20B—C20—H20C 109.5 
C10—C9—C8 120.5 (3)   
C5—N1—C1—C2 −0.4 (5) O1—C10—C11—C12 179.7 (3) 
Pd1—N1—C1—C2 −180.0 (γ) C9—C10—C11—C12 0.9 (6) 
N1—C1—C2—C3 −1.β (6) O2—C11—C12—C13 177.9 (3) 
C1—C2—C3—C4 2.0 (6) C10—C11—C12—C13 −1.β (6) 
C2—C3—C4—C5 −1.γ (6) C9—C8—C13—C12 0.3 (5) 
C1—N1—C5—C4 1.1 (5) C7—C8—C13—C12 −178.0 (γ) 
Pd1—N1—C5—C4 −179.γ (3) C9—C8—C13—C14 176.3 (3) 
C1—N1—C5—C6 −175.8 (γ) C7—C8—C13—C14 −β.0 (5) 
Pd1—N1—C5—C6 3.8 (4) C11—C12—C13—C8 0.7 (6) 
C3—C4—C5—N1 −0.β (5) C11—C12—C13—C14 −175.4 (γ) 
C3—C4—C5—C6 176.6 (3) C17—N2—C16—N3 −0.4 (4) 
C13—C8—C9—C10 −0.6 (5) Pd1—N2—C16—N3 178.0 (2) 
C7—C8—C9—C10 177.7 (3) C17—N2—C16—C15 178.1 (3) 
C19—O1—C10—C9 9.7 (5) Pd1—N2—C16—C15 −γ.5 (5) 
C19—O1—C10—C11 −169.0 (γ) C18—N3—C16—N2 0.5 (4) 
C8—C9—C10—O1 −178.6 (γ) C18—N3—C16—C15 −178.0 (γ) 
C8—C9—C10—C11 0.1 (6) C16—N2—C17—C18 0.2 (4) 
C20—O2—C11—C12 −1β.7 (5) Pd1—N2—C17—C18 −178.0 (γ) 
C20—O2—C11—C10 166.5 (3) N2—C17—C18—N3 0.0 (4) 
O1—C10—C11—O2 0.4 (5) C16—N3—C18—C17 −0.γ (4) 
C9—C10—C11—O2 −178.4 (γ)   
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Appendix A-21. Hydrogen-bond geometry (Å, °) for 13.PdCl2 
 
D—H···A Donor—H H···Acceptor Donor···Acceptor Angle 
C2—H2···Cl2 0.95 2.86 3.510 (4) 127 
N3—H3N···Cl2 0.87 (5) 2.43 (5) 3.242 (3) 156 (4) 
C17—H17···O1 0.95 2.47 3.380 (4) 160 
C17—H17···O2 0.95 2.57 3.317 (4) 136 
C18—H18···Cl1 0.95 2.92 3.665 (4) 137 
C19—H19C···Cl1 0.98 2.94 3.785 (5) 145 
C20—H20B···Cl1 0.98 2.83 3.750 (4) 156 
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Appendix B: CheckCIF-reports for all studied compounds. 
 
Appendix B-1. CheckCIF reports for compound 2 
 
Bond precision: C-C = 0.0041 A Wavelength=0.71073 
Cell: a=8.7561(5) b=9.0016(5) c=12.8869(7) 
 alpha=90 beta=90 gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 1015.73(10) 1015.73(10) 
Space group P 21 21 21 P 21 21 21 
Hall group P 2ac 2ab P 2ac 2ab 
Moiety formula C10 H9 I N2 C10 H9 I N2 
Sum formula C10 H9 I N2 C10 H9 I N2 
Mr 284.09 284.09 
Dx,g cm-3 1.858 1.858 
Z 4 4 
Mu (mm-1) 3.107 3.107 
F000 544.0 544.0 
F000' 542.26  
h,k,lmax 11,11,16 11,11,16 
Nref 2229[ 1303] 2228 
Tmin,Tmax 0.479,0.856 0.622,0.746 
Tmin' 0.390  
Correction method= # Reported T Limits: Tmin=0.622 Tmax=0.746 
AbsCorr = MULTI-SCAN 
 
Data completeness= 1.71/1.00 Theta(max)= 27.087 
R(reflections)= 0.0129( 2202) wR2(reflections)= 0.0300( 2228) 
S = 1.051 Npar= 118 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level G 
PLAT431_ALERT_2_G Short Inter HL..A  Contact I1     ..  N2      ..       2.88 Ang.   
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          8 
Note   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   0 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
   2 ALERT level G = General information/check it is not something unexpected 
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   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   2 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   0 ALERT type 3 Indicator that the structure quality may be low 
   0 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
Datablock I - ellipsoid plot 
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   0 ALERT level B = A potentially serious problem, consider carefully 
   1 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
   3 ALERT level G = General information/check it is not something unexpected 
 
   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   3 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   0 ALERT type 3 Indicator that the structure quality may be low 
   1 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
 
 
Datablock I - ellipsoid plot 
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Appendix B-3. CheckCIF reports for compound 5 
 
Bond precision: C-C = 0.0028 A Wavelength=0.71073 
Cell: a=8.4574(5) b=6.1526(3) c=19.4261(10) 
 alpha=90 beta=96.362(1) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 1004.61(9) 1004.61(9) 
Space group P 21/n P 21/n 
Hall group -P 2yn -P 2yn 
Moiety formula C10 H9 I N2 C10 H9 I N2 
Sum formula C10 H9 I N2 C10 H9 I N2 
Mr 284.09 284.09 
Dx,g cm-3 1.878 1.878 
Z 4 4 
Mu (mm-1) 3.141 3.141 
F000 544.0 544.0 
F000' 542.26  
h,k,lmax 10,7,24 10,7,24 
Nref 2208 2207 
Tmin,Tmax 0.506,0.501 0.594,0.746 
Tmin' 0.496  
Correction method= # Reported T Limits: Tmin=0.594 Tmax=0.746 
AbsCorr = MULTI-SCAN 
 
Data completeness= 1.000 Theta(max)= 27.108 
R(reflections)= 0.0161( 2114) wR2(reflections)= 0.0367( 2207) 
S = 1.106 Npar= 118 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level G 
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600          2 
Note   
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          9 
Note   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   0 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
   2 ALERT level G = General information/check it is not something unexpected 
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   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   1 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   0 ALERT type 3 Indicator that the structure quality may be low 
   1 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
 
 
Datablock I - ellipsoid plot 
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PLAT072_ALERT_2_G SHELXL First  Parameter in WGHT  Unusually Large       0.11 
Report 
PLAT172_ALERT_4_G The CIF-Embedded .res File Contains DFIX Records          1 
Report 
PLAT371_ALERT_2_G Long    C(sp2)-C(sp1) Bond  C5     -   C6     ..       1.44 Ang.   
And 3 other PLAT371 Alerts 
More ... 
PLAT860_ALERT_3_G Number of Least-Squares Restraints .............          1 Note   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600          9 
Note   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   4 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
   9 ALERT level G = General information/check it is not something unexpected 
 
   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   7 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   4 ALERT type 3 Indicator that the structure quality may be low 
   2 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
 
 
Datablock I - ellipsoid plot
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PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X)  Pd1    --  Cl2     ..       12.2 s.u.   
PLAT371_ALERT_2_G Long    C(sp2)-C(sp1) Bond  C5     -   C6     ..       1.44 Ang.   
And 2 other PLAT371 Alerts 
More ... 
PLAT605_ALERT_4_G Largest Solvent Accessible VOID in the Structure        209 
A**3   
PLAT802_ALERT_4_G CIF Input Record(s) with more than 80 Characters          1 Info   
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE Suppressed           ! 
Info  
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600          3 
Note   
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          6 
Note   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   5 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
  10 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   6 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   1 ALERT type 3 Indicator that the structure quality may be low 
   7 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
PLATON version of 27/03/2017; check.def file version of 24/03/2017 
Datablock I - ellipsoid plot 
 
 
 
